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1. 
INTRODUCTION 
Manganese  was discovered by S cheele in 17 7 4  and isolated 
in pure form by Gahn in .�8 0 7  (Von Oettingen , 1 9 3 5) .  
Indications of  manganese as a nece s sary trace element 
in anima l  nutrition was presented by McHargue (19 2 6) .  
Although there i s  considerable interest  in the phys iological 
and biochemical  role of manganese by many workers , its ro le 
as a trace metal in biological systems i s  not completely 
known . In vitro experiments' with manganous ion indicated 
that mangane se appeared to be a co-factor of alkaline 
phosphatase and arginase {Boyer et al . , 1 9 4 2 ) . 
Underwood {19 7 1) mentioned that a manganese-iron ratio 
was of much greater  importance than commonly believed , 
since manganese  could replace or antagoni ze iron in certain 
enzymatic and biochemical reactions ( Yone tani and Asakura , 
1 9 68) . 
No form o f  animal life amas sed manganes e  according to 
s tudies by S chroeder et al . (1 9 6 6) .  Exces s  manganese ions 
may cause phys iological dysfunctions as was reported by 
Mena et a l . {1 9 6 9) .  
Manganese  intoxication in ruminants has not been 
reported under field conditions . 
Thi s  investigation i s  des i gned to provide new i�forma­
tion concerning the effects of toxic leve l s  of manganese on 
the fol lowing b lood components . of sheep : plasma and 
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erythrocyte ( red blood ce lls ) iron and manganese ; erythrocyte 
and leucocyte (white blood cel ls ) counts;  hemoglobin 
concentrations and packed ce l l  volumes ; Wintrobe indices; 
di f ferential counts and body we ights . 
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LITERATURE REVIEW 
Manganese , atomi c number 2 5; molecular we i ght 5 4 . 9 ,  is  
a trace metal of the transition group . Trace minerals 
whi ch originate from metals  of the firs t trans i tion series 
can have similar e lectronic s tructure ( Thomas , 19 7 0) .  All 
trace minerals except chromium and copper have two electrons 
in their  4 s  orbital . The 3d orbi tal of trace metals becomes 
progre s s ively more fi lled with electrons from calcium, 
which has no e lectrons in its  d orbital, to z inc , which has 
a full d orbi tal . Ions of the trace elements can· accept 
electrons from donor atoms into the 3d orbital, further, · 
they can lose an electron from this  orbi tal . These  proper­
ties cause the trace minerals  to have s imil ar chemical 
chemi s try . In several instances, one 0£ thes e  metals can 
replace , or antagoni ze , another element of the s ame series . 
Yonetani and Asakura ( 19 68 ) , s tudying the crystalline 
enzyme cytochrome c peroxidase recons ti tuted from manganese 
protoporphyrin and apoenzyme, concluded that manganese can 
s·ubs ti tute for p·art of the iron in the prosthetic group of 
heme-containing enzymes . 
·Trans ferrin , a globulin , is  the iron- carrying compound 
in· blood . I t  has two metal binding s i te s; however , as 
Ai sen et  al . ( 19 6 9 )  has indicated , other trace metals such 
as manganese, cobalt and chromium can form specific 
complexes with trans ferrin . Behaviour of  these compounds 
was s imi lar to that of the iron- trans ferrin complex . For 
example, manganese, chromium , or cobalt- trans ferrin com­
plexes b ind bicarbonate in a ratio to the metal ion near 
one, as is the case of the iron-trans ferrin complex . 
Manganese  Metabolism 
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The importance of manganese as a trace e lement has been 
inve s tigated by many people, and special attention has been 
given to re lationships of other trace metals  to ma�gane se 
intake . 
Studies by Greenberg et al . ( 19 4 3 ) . indicated that 
3 to 4 percent of the radioactive manganese  adminis tered 
orally was absorbed into the body of rats . However , Carter 
et al . ( 1 9 7 4 ) , us ing male Holstein calves fed whole milk 
or whole mi lk supplemented with 15 parts per mi l lion (ppm} 
manganes e  and given  an ( IV )  inj ection or an oral  dos e  of 
radioactive manganese ( 5 4Mn)  found that calves  fed an 
unsupplemented mi lk diet had a higher manganes e  absorption 
and retention than recorded by previous workers  ( Greenberg 
et  al� 1 9 4 3 ) . These workers found that adminis tration of 
15 ppm dietary manganese drastically reduced the percent�ge 
of an oral dose of radioactive manganese  <5 4Mn)  whi ch was 
absorbed and retained in calves . 
Britton and Cot zias (1966) found that  turnover of 
radioactive manganese c5 4Mn) admini stered oral ly i s  
directly re lated to the dietary level of s table manganese 
in mice . Also , concentration of ti ssue radiomangane se 
(54Mn) was related to the dietary manganese concentration . 
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They concluded that variab le excretion rather than variable 
absorption reguiates tissue manganese . 
Pol lack et  al . ( 1965 ) indicated that absorption of 
coba lt , manganese ,  and iron increased in iron deficient rats . 
This  can be attributed .to the atomic s imi lari ty of these 
elements .  However , Thomson and Valberg ( 1�72) s tudied 
intestin·a1 uptake of cobalt , manganese , and i ron in iron­
deficient rats and found that absorption of the three 
elements involved s imi lar binding s ites in the intes tinal 
mucosa! layer . These authors indicated that iron is 
absorbed via a two- s tep mechanism :  firs t , iron is absorbed 
from the lumen and , secondly , it i s  transferred across the 
. luminal cells  into the blood . Mangan.ese , cobalt and iron 
in iron-deficient rats compete for binding s i tes in the 
transfer s tep . 
Thomson et al . ( l971) showed that in i ron loaded 
animals , a small  portion ( 2 0%)  of orally adminis tered man­
ganese  was absorbed by the duodenum , j ej unum and ileum . .  In 
normal animals , manganese absorption was s li ghtly higher in 
the duodenum then in jej unum and i leum , but not 
significantly . In iron-defi cient anima l s , a s ignificant 
increase in manganese uptake and transfer occurred in the 
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duodenum and j e j unum ; however , manganese  uptake did not 
change . in the i leum with variation in i ron store s . These 
workers suggested that this increased mangane se uptake in 
iron-deficient animals was medi ated by the iron transport 
mechanism . Mena et al . ( 1969) s tudying chronic manganese 
poi s oning among miners indicated tha� the re was a c lose 
relationship between rates of dietary i ron and manganese 
absorption in anemic and normal humans and in chronic 
manganese poisoning . Mi ller et al . ( 1972 ) observed that 
small  intes tine mucousal layer released'and absorbed 
radioactive manganese  c54Mn) rapidly , with much of manganese 
returning to the intes tinal contents .  The s e  authors con­
c luded that radiomangane se c54Mn) transport from the small 
intestine , rather than uptake , controls  carcas s mangane se 
concentration . Papvas i l ious et al . ( 1966) inves tigating 
gas trointestinal routes of manganese excretion indicated 
that the duodenum and j ej unum excreted more manganese than 
the terminal i leum .  Carter et al . · ( 1974) s ugge s ted that 
both excretion and ab�orption are maj or mechanisms by which 
manganese homeos tatic needs are regulated over the wide 
range pf manganese  intake found under fie ld condi tions . . 
Grace ( 1975 ) s tudied flow of s everal trace e lements 
acros s the dige s tive tract of sheep and concluded that diet 
does not influence net movement of trace metals across  the 
diges tive tract wail . This author found a net absorpt£on 
of z inc , copper , cobalt  and manganese from the large 
intes tine irre spective of diet . 
Cotz ias . et  al . (1966 ) found that regulation of tissue 
manganese was accompli shed primar i ly by active excretion . 
Thi s  active excretion occurs via bile and via the inte st­
inal  muco s a . Under normal circums tance? , bile was the 
ma in route of  manganese excretion ; moreover ,  the biliary 
leve l of mangane se was re�ated to mangane se intake and to 
the bil irubin content of bile (Maynard and F ink , 1956) . 
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Excre tion o f  manganese via pancreatic j uice is  pos s ible . 
This  pathway is  used when the biliary route i s  blocked or 
when manganese overloading occurs (Papava s i l iou et al . ,  
19�6 ) . These authors also found that the k idney excreted 
small  amounts of manganese during hepati c  d isorders or 
manganese pver- loading . 
Las s iter , Morton , and Mi ller ( 1970) demons trated that 
high dietary phosphorus had no e ffect on oral manganese 
retention ; however ,  high calcium diets caused increased 
radiomanganese  excretion . 
Mangane se a·nd Blood 
Manganese was demons trated as a con s t ituent of blood 
in 1844 by Marches s aux and was confirmed i n  1847 by Mi llion ; 
further confirmation and a pos s ible funct ion in erythrocytes 
and anemia was provided by Burin de Buis s on in 1952 (Von 
Oettingen , 1935 ) . Von Oe�tingen (1935 )  a l s o  indicated 
that Buchheim in 1 8 7 8 , uti li z ing dogs , was unable to increase 
erythrocyte ( red blood ce ll ) manganese content . 
Manganese i s  transported in blood in  a trivalent form 
by a B1- globulin , transmanganin ; one manganese ion can bind 
more than one prote in molecule (Cotzias , 1 9 5 8 ;  Underwood , 
1 9 7 1 )  • 
Hartman et  a l . ( 1 9 5 5 )  uti li zed young growing lambs 
dep leted o f  i ron , fed various mang�nese leve l s  and found 
that die tary manganese levels  as low as 4 5  ppm caused 
decreased hemoglobin and serum iron concentrations . The se 
workers  s uggested that the cause of decreased hemoglobin 
formation was manganese interference with i ron absorption 
rather than wi th hematopoies is . They pos tul ated that 
manganese antagoni zed en zymes involved in oxidation of i ron 
at the s i te of absorption . Also , highes t  manganese intake 
was a s sociated with the lowest  serum i ron . 
Beard et  al . ( 19 3 1 )  s tudied the e f fect o f  iron and iron 
supplemented with copper , manganese , arseni c , germanium , 
uranium ,  and z inc in . anemic rats and found that optimum doses 
of these  metals added separate ly to . 2 5 mg of  i ron resulted 
in no-greater degree of reticulocytos i s , nor did erythrocyte 
formation occur more quickly than with i ron a lone . However , 
a large decrease occurred in re ticulocyte numbe r on the 
fi fth and s ixth day after injection . A rapid increase in 
erythrocyte number and hemoglobin concentration was evident . 
These authors concluded that these supplements increased 
the rate of maturation of erythrocyte s. Myers and Beard 
( 1 9 3 1 )  indi cated tha t metals such as copper, mangane se , 
zinc , selenium ,  and mercury , when fed individually with . 5  
mg of iron to anemic rats , e licit hemoglobin regeneration 
and erythrocyte recovery fas ter  than iron supplementation 
alone . 
Manganese  employed as the only treatme nt of  anemia in 
rats had no e f fect on blood parameters or on blood re-
generation in the erythroblastic sys tem of bone marrow 
(Mackiewic z , 1 9 6 5a ) . In  a later s tudy , Machiewic z  ( 1 9 6 5b )  
indicated that simultaneous adminis tration of manganese 
and. iron was more. effective in s timulating b lood re-
generation and the bone marrow erythroblas tic sys tem than 
treatment with iron alone . 
Wachte l  e t  al . ( 19 4 3 )  s tudied mangane s e  deficiency in 
rats and concluded that rats with a severe manganese 
defi ciency had poorer body growth and bone formation , 
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s l ightly decreased hemoglobin concentration , and some 
interference with hemoglobin regeneration than control rats . 
Studies of  mangane se- i ron re lationship in pregnant and 
fetal rabbits  ( C izadlo , 1 9 7 2 )  indicated that intraperitoneal 
admini stration of 10 to 20  mg Mn/kg body wei ght had no 
effect on reticulocyte , erythrocyte or  leucocyte counts , 
. 
hemoglobin concentration , packed cel l  vo lume , Wintrobe 
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indices , plasma and erythrocyte iron and manganese  con­
centration of doe rabbits . However , feta l rabbi t  data 
showed s igni ficant changes due to manganese administration . 
Increased reticulocyte and decreased leucocyte counts , 
depre ssed hemoglobin concentration and inc reased erythocyte 
manganese concentration were evident .  Also , fetal body 
weight was reduced . These results are in  agreement wi th 
studies of Kerr ( 1975) although experimenta l  sub j ects were 
different . Kerr ( 1975) , s tudying the e ffects of  manganese 
on blood of  male rabbits , indicated that adminis tration of 
manganese caused alteration in reticulocyte , leucocyte , 
neutrophi l , lymphocyte , basophil counts , and hemoglobin 
concentration , also Wintrobe indices . 
Evidence o f  manganese porphyrins in erythrocyte s was 
produced by Borg and Cotz ias (1958) � In an in vivo study , 
these authors found that patients inj ected wi th radio­
manganese · ( 54.Mn) incorporated almos t al l of the manganese 
into erythrocytes after 66 days . Furthermore , ins ignificant 
levels of manganese were within the s troma of the ce ll or 
he huffy coat . These workers conc luded that  manganese was 
bound into an inner structural component of erythrocytes .  
I n  vi tro s tudies of  Weed and Roths tein ( 1960) indicated that 
rate of entry of manganese into erythrocytes depended upon 
plasma manganese concentration . Also , calcium reduced 
manganese entry into ce lls. Of all manganese  that moved 
11  
into ce lls , 40 to 6 0  percent was converted to  a non­
ultrafi l terable form; therefore , a rate o f  e ff l ux of one­
half of  the inf lux of manganese existed . Thes e  authors also 
sugges ted that since manganese cannot bind to heme molecules 
in mature erythrocytes , compounds such as ATP , enolase or 
2-phosphob lyce ric acid must have bound the manganese . 
Waterman and Yonetani ( 1 9 7 0) prepared hybrid hemo­
globin containing manganese and iron subunits . In vitro 
studie s indicated that manganese subunits bound neither 
oxygen nor carbon monoxide , while iron· s ubunits bound both . 
The lowered affinity of manganese subunits for oxygen and 
carbon monoxide was attributed to the presence of an 
unidentified pros the tic group . 
Low manganese concentration in b lood has made measure­
ment difficul t ; me thods such as neutron activation analysis 
or atomic absorption spectrophotometry have been used to 
determine manganese concentration in human and animal 
tis sues . Cot zias e t  al . ( 1 9 6 6 ) used neutron activation 
analys is  and reported 8.44+ 2 . 73 ug Mn/liter of whole b lood 
and . s9+ . 18 ug Mn/liter of plasma . Manganese concentrations 
of  approximately 20 ug/liter for cal f whole blood were 
reported by Hawkins et al . ( 1 9 5 5) .  
Manganese Toxicity 
Manganese is . among the least toxic  o f  the trace metals 
to mammal s . However ,  toxic manganese concentrations can 
cause physiological problems . Becker and Mcco llum ( 1 938 ) 
indicated that excess dietary mangane se reduced growth 
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rates in rats . Manganese , like beryl lium ,  i ron , and alum­
inum , was rachitogenic when administrated in large amounts 
to growing rats ( Charnock et  al . , 1 9 42) .  These workers also 
mentioned that growth retardation of rats was proportional 
to manganese intake . 
Manganese fed at 50 0 or 1 0 0 0  ppm depres sed iron absorp­
tion. in rats (Hansard et al . , 1 9 6 0 ) . Also th�se workers 
noted that adminis tration of  exces s  mangane s e  in low phos­
phorus diets reduced iron uti li zation by erythrocytes and 
decreased iron concentration in liver , spleen , and femur . 
Increased erythrocyte count , decreased body weight , and 
decreased hemoglobin concentration were found by Moinuddin 
and Lee ( 1 9 6 0 )  when high levels  of mangane se  sul fate (Mnso 4) 
were fed to rats . 
Matrone et  al . ( 1959 } showed that hemoglob in formation 
and growth in rabbits and baby pigs fed 2 0 0 0  ppm manganese 
were depre s sed . However, supplementation with 4 0 0  ppm diet­
ary iron overcame the depressing e ffec t  of  2 0 0 0  ppm 
mangane se on hemoglobin formation . 
Svaj gr et al: ( 1 9 6 9 } showed that average daily . gain 
was signi ficantly reduced when swine diets  were supplemented 
with �O ppm manganese . Wade ( 1 9 7 2 ) s tudyi�g .manganese  
toxicity in swine indicated that there were no  s igni ficant 
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changes in mean corpuscul ar volume and plasma manganese of 
treated Duroc or Hampshire
. 
gilts. However, mean corpuscular 
hemoglobin concentration, and plasma iron were different in 
the two breeds after treatment. This author concl uded that 
there were breed and treatment dif ferences between Duroc 
and Hampshire gilts, since Duroc gilts exhibited much
. 
greater 
toxic response to manganese. injection. 
Robinson et al. (1960) studied th� effect of excess 
diet�ry manganese on beef cattl e and found that supple­
mentatio� with O, 250, 500, and 1000 ppm manganese (Mnso4) 
did not aff ect packed cell volume, hemoglobin concentration, 
and plasma iron concentration. Howeve�, tissue anal ysis 
showed in�reased manganese concentration and iron depletion. 
Cunni�gham et al . (19 62) showed that excess dietary 
manganese caused decreased feed intake, f eed efficiency and 
. growth of calves. In a l ater study, Cunningham et al. 
(1966) stated that body weight gains, feed intake, and 
hemoglobin f ormation were_ 
greatly depressed when calves were 
f ed high dietary l evels of manganese. Depressed volatile 
f atty acid productio� and marked changes in rumen fl ora were 
ob�erved by these worke�s when animals were f ed high levels 
of manganese. 
Ivan and Grieve '(1975) reported that high dietary 
manga�ese caused increased zinc concentration_ in calf l iver, 
kidney, and h�art. ·coppe� concentration in l iver was 
318337 
.SOUTI-1 DAKOTA ST A TE .UNIVERSITY LIBRARY 
1 4  
increased with dietary manganese supplementation . Excess 
manganese · in the die t caused a 1 7  percent decrease in growth 
rate of Ho ls tein calves . However , urinary excretion of 
manganese decreased with manganese adminis tration . 
Hartman e t  al . ( 19 5 5) s tudied e ffects of  high die tary 
mangane se on hemoglobin formation in lambs and concluded 
that supplementation of milk diets with 4 5  to 5 0 0 0  ppm 
manganese  for 3 5  weeks caused decreased hemoglobin levels . 
Als� , high manganese levels  in roughage diets  caused 
hemoglobin depression . Serum iron was lowered in both 
diets with exces s  manganese supplementation . These authors 
pos tulated tha t  decreased hemoglobin concentration was due 
to mangane se inte rference with iron absorption , hemoglobin 
formation , or both . 
Lower leve ls  of  iron or zinc and higher leve l s  of  
copper in l iver were reported by Watson e t  al . ( 1 9 7 3) in 
sheep fed high dietary manganese . The. greate s t  s torage o f  
mangane s e  i n  animals fed high manganes e  leve l s  was i n  liver , 
kidney , heart , and spleen . These t i s s ue s  are rich in 
mitochondria , and this  finding is in agreement wi th the 
theory that the functional activity o f  manganese  is  located 
in mitochondria . 
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EXPERIMENTAL PROCEDURE 
Se lection o f  Experimental Animals 
. Twe lve Cross-Finn she.ep from the South ·nakota S tate 
Univers i ty f lock were uti li zed in thi s  inve�tigation . They 
weighed 4 2 . 73 to 5 7 . 2 7  kg , averaging 5 0 . 30 k i lograms . 
Experimental animals were sheared and housed in a cemented 
floor pen covered with s traw .  Subj ects had dry hay and 
water ad ·1ibitum . The ·trial period was during month� of 
Apri l ,  May , and June . · Attention was given to thermost�tic 
control o f  the room to minimi ze ·temperature f luctuations . 
General P rocedure 
S tock solutions were prepared uti l i z ing research_ grade 
NaCl and Mnc1 2·4H2 o and double disti lled deioni zed water .  
Corrections were made for water o f  hydration and chlorine 
so that the ma�ganese solution had 7 . 5 mg/ml of elemental 
mangane se . 
Animals were we ighed before each bleeding . Subj ects 
were bled via the j ugular vein employing a California bleed­
ing needle , s i ze 1 4 . Fifteen ml of  blood was - col lected in 
three 5 -ml plas�ic tubes , 1 each containing 157 0  units of 
sodium heparin , to prevent blood coagulation . The first four 
1Falcon Co . , Oxnard , Cali fornia . 
1 6  
weekly bleedings were employed t o  determine base line 
parameters . At weeks five and s ix of the 
'
experiment the 
control group ( 4  sheep ) rece ived inj ections o f  saline , while 
the treatment group ( 8  sh�ep ) were inj ected with 5 mg Mn/kg 
of body weight . All inj ections were intraperitoneally via 
left  para lumbar fos sa area . Volume of  inj ections were 
adj usted to 4 0  ml per animal uti l i z ing 5 0  cc syringes with 
15  gauge needles . At weeks seven , e ight , and nine , the 
e ffects of pos t  manganese-toxicity were observed without 
manganese or s alin� being adminis tered . 
Hemogram Dete rminations 
Erythrocyte s and leucocytes (wh ite blood cells ) counts 
were obtained immediately fo llowing bleeding using 5 ml of 
blood reserved for hemogram determinations . Almos t all 
parameters we re determined wi thin 4 hours after bleeding . 
The e rythrocytes were counted us ing a Coul ter  Counter Model 
p2 which was s tandardi zed for sheep red c e l l s  with attenua­
tion set  at . 7 0 7 , aperature set at 8 ,  and threshold set a t  
13 . The 5 0 , 0 0 0  f�ld di lution for erythrocyte was accomplished 
in two s teps . Firs t , the 5 0 0 fold di lution was rnaae for 
leucocyte enumer�tion and from it a further di lution gave 
2coulter Electronics , Inc . , Hialeah , Florida . 
the 1 to· 50, 000 'dilution ratio. Dilutions were made by 
employi�g a Coulter Counter Dual-Dil uter
3 and Isoton4 as 
diluent. To correct counting errors made by passage of 
2 or more cells at one time through the system, a Coulter 
Counter Coincidence Correction Charts was used to give 
final counts. 
Total l eucocyte counts we�e obtained by the same 
procedure used for erythrocyte count except that there was 
a 500-fold dil ution, and aperature was set at 16, al so 
threshol d was set at 4. Zap-Isoton, 6 a l ysing agent, was 
used to lyse all erythrocytes before l eucocyte counts were 
determined. 
1 7 
A microhematocrit method w�s employed to. measure packed 
cell volume (PCV) in duplicate by using Yankee Micro 
Hematocrit tubes? and an Adams Autocrit Centrifuge.
8 
3coul ter Electronics, Inc. , Hialeah, Fl orida. 
4coul ter Electronics, Inc. , Hialeah, · Florida. 
5coulter -Electronics, Inc. , Hialeah, Florida. 
6cou.lter Diagnostics, Inc., Miami Springs, Florida. 
7c1ay Adams, Inc. , New York, New York. 
8c1ay Adams, Inc., New York, New York. 
Capi lla ry tube s we re centri f uge d fo r 5 mi nute s a nd vo lume s 
we re re ad f rom the c e ntri f uge s c ale .  
Hemog lo bi n  c o nce ntra tion wa s de te r mined i n  d up li cate 
by emplo y i ng the Hyc e l ,
9 
Cyanme themo g lo bi n  Techni que and a 
Bec kma n Gra ti ng S pe c trophotome te r  Mod e l  DB-G. 10 Hemoglobi n  
va lue s for e ach s h eep we re the n  ob ta i ne d  us i ng the s lope 
of a s ta ndard c urve whi ch was made by uti li za ti o n  by Hyce 111 
h emoglo bi n s tand a rd . Tota l  hemoglo bi n  d e te rmi ne d  by th i s  
me thod i nc lude s rne themoglo bi n ,  carbohemo g lob i n ,  c a rboxy-
hemo glob i n ,  and oxyhemoglobi n  but i t  doe s  no t me a s ure 
s ulfhemo g lo bi n  (Hyce l 1971). 
The Wi ntrobe i nd i c e s  which i nc lude me a n  c o rp us c ular 
vo lume (MC V) , me an corp us c ular hemoglo bi n _(MC H) , and me an 
corp us c ular hemo g lo bi n conce ntrati o n  (MC HC ) were de termi ned 
e mp loyi ng the fo llowi ng formulas : 
MC V (c ubi c mi c rons )  
pac ked c e ll vo lume x 10 
= 
ery throcyte s , mi llion/c ubic mm 
9Hyc e l Cya nrne themoglo bi n De te rmi na ti o ns , Hyc e l ,  Inc . , 
Ho us to n ,  Tex a s .  
lOB ec krnan Ins trume nts , Inc . , Fulle rto n ,  C a li fo r ni a .  
llHyc e l Cy anme themoglo bi n  De termi nati o ns , Hyc e l ,  Inc . , 
Ho us ton, Tex as .  · 
MCH (rnicrornicrograms ) = g hemoglobin/1 0 0  ml b lood x 1 0  
erythrocytes ,  mi l lion/cubic mm 
MCHC . (percent ) = g hemoglobin/ 1 0 0  ml b lood x 1 0 0  packed ce ll volume , percent 
Blood smears were prepared to obtain leucocyte 
differential counts . Sheep blood i s  concentrated in 
erythrocyte s ,  therefore a 50 : 50 dilution of b lood with 
phy s iological saline was made before smears were made for 
di f ferential counts .  Blood smears were then s tained us ing 
19 
Wright's s taining technique outl ined by Davidson and Ne lson 
( 1 9 6 9) .  
Iron and Manganese Determination 
Erythrocyte s and plasma were separated for iron and 
mangane se de terminations by centri fuging 1 0  ml of  shee� 
blood for 30 minutes in an International C l inical Centrifuge 
Mode l c1-212 . Plasma was removed and placed in 5 ml plastic 
tubes . Five ml o f  sal ine was added to the erythrocyte 
portion of e ach sheep blood and the tube s were wel l  mixed . 
The mixture of  saline and erythrocytes was centrifuged for 
12rntern�tional Equipment Co . ,  Needham He ights , Mas s­
achusetts . 
2 0 
3 0  minute s , then the supernatant was removed and discarded . 
The purpose of the addition of saline to ery throcytes was to 
remove the exce s s  plasma . Erythrocyte portions were placed 
in 5 ml plastic tubes and together with p lasma s ample s  
were re frige rated unti l further proces s ing for i ron and 
mangane se determinations . 
Flame le s s  Atomic Absorption Spectrophotometry was used 
to determine manganese in all samples and i ron in  plasma . 
Iron in the erythrocyte portions was determined by 
conventional flam� atomic absorption . P lasma was di luied 
1 0  fold uti l i z ing a Repipet Di lutorl3 to obtain mangane se 
and iron leve l s  in the plasma . . A solution of . 1  percent 
(v/v ) of Triton X- 1 0 0  was employed as di luent . Erythrocyte 
portion was di luted 1 0  times for manganese  us ing Tri ton 
and was diluted an addi tional 2 0  times to . give a 200 -fold 
di lution for iron determination . Al l di lutions were made 
in duplicate . Pre liminary work with the s ample dilution 
gave recoveries of 1 0 2  to 1 0 4  percent for manganese and 9 6  
to 9 7  percent for iron . These results were comparable to 
those obtained for nitric acid dige s ts of the s ame samples . 
However ,  use of perchloric acid in a predige s tion procedure 
was found to interfere with the manganese  determination . 
1 3sa�gent-Welch Scientific Co . ,  Dallas , Texa s . 
21 
Dry ashing also caused some problems since a portion of the 
iron from the erythrocytes was difficult to dis solve . 
A mode l 5 0 3  Perkin-Elmerl 4  Atomic Absorption 
Spec'trophotome te r equipped with HGA2 1 0 o l 5  heated graphite 
atomizer and a Deuterium Arc Background Correctorl 6  was 
used for manganese and iron determinations in plasma and 
manganese  in erythrocyte . Conventional Flame Atomic 
Absorption using a Perkin-Elmer Atomic Absorption 
.. 
Spectrophotometer Model 3 0 3 1 7  was employed to determine 
iron in e rythrocyte portions of  the b lood! 
I ron s tandards included . 1  ug Fe/ml (ppm) for use with 
. Flamele s s  Atomic Absorption Spectrophotometer , also 2, 5, 
and 10 ug Fe/ml (ppm) for use in conventional Flame Atomic 
Absorption Spectrophotometer . Manganese  s tandards included 
.OS and 1 ug Mn/ml ( ppm ) . Standards were run following 
every twe lfth blood sample . 
Since Flame le s s  Atomic Absorption Spectrophotometer is 
a sensitive technique , small volumes of s amp le are needed 
14Perkin-Elmer Corp . ,  Norwalk, Connecticut .  
1 5Perkin-Eliner Corp . ,  Norwalk, Connecticut .  
1 6Perkin-E lmer Corp . ,  Norwalk, Connec ticut . 
1 7Perkin-E lmer Corp . ,  Norwalk, Connec tic'l,lt . 
for analys i s . Eppendorf 1 0 , 20, and 5 0  microli ter pipets 
2 2  
were employed to inject the · nece ssary vo lume of s ample into 
the graphi te tube for determination of iron and mangane se . 
Atomic Absorption Spectroscopy i s  bas ed on absorbance 
of light energ� at wave lengths characteris tic of each 
element . The ins trument then needs speci f i c  hol low cathode , 
lamps and special  settings for each e lement . 
Standard Settings For Manganese Determination Using 
Perkin-Elmer Atomic Absorption Spectrophotometer 
Mode l 5 0 3 . 
Cathode current set at 2 0  mi lliamperes 
Absorbance wave length set at 2 7 9 . 5  nm ( uv)  
Deuterium Background Correc tor set  a t  Maximum 
Reference Energy 
S l i t  width set  at . 2  nm 
Drying Temperature llO (OC )  Maximum , time = depends 
on volume of sample injected 
Maximum Charring Temperature 1 2 0Q ( OC ) , time = 
3 0  seconds 
Optimum Atomi zation Temperature 2 7 0 0 (oc ) , time = 
7 seconds 
Standard Settings For Iron Using Perk in-Elmer· Atomic 
Absorption Spectrophotometer Model 5 0 3 .  
Cathode current set at 3 0  mi l liamperes 
· Absorbance wave length set at 2 48 . 3 nm 
S l i t  width set at . 2  nm 
Drying Temperature 1 1 0 , time = depends on volume 
o f  sample inje cted 
Maximum Charring Temperature llO O (OC) , time = 
30 seconds 
Optimum Atomi zation Temperature 2 7 0 0 (0C ) , time = 
7 seconds 
Standard Settings For· Iron Us ing Perk in-Elmer Atomic 
Absorption Spec trophotome ter Mode l  3 0 3 .  
Cathode current set at 2 0  mi lliamperes 
Sli t  width set at . 2  nm 
Scale set at 1 
Absorbance recording needle and s ca le set at zero 
Calculation o f  Iron and Manganese Concentration 
2 3  
P lasma and erythrocyte mangane se , also plasma iron were 
calculated us ing the fol lowing formulas� 
where 
Concentration of  manganese or i ron in blood = 
blood sample absorption x di lution 
standard k 
Standard k = absorption of standard x 
concentration of standard 
volume of b lood sample used 
volume of s tandard used 
24 
Iron in erythrocyte portion was calculateQ using the 
same principle , with the exception that in s tandard k 
calculation , volume of s a�ple over volume of s tandard was 
el iminated due to the sameness of the volume in both cases . 
2 5  
RESULTS AND DISCUSSION 
Means of  parameters from the first four consecutive 
bleedings are recorded in Table 1 .  MCV and MCH values were 
higher than those values recorded by S chalm ( 1 9 6 1), although 
within the normal range . 
Toxic responses appeared 2 to 3 hours after manganese 
inj ections . Subj ective observations included an apparent 
reduction in· physica l  activity, decreased water and feed 
intake, and abdominal sens itivity . 
Values of  parameters for weeks one thro�gh nine ( Plan 
A)' and weeks five through nine ( P lan B )  were analyzed by 
least- square s analys i s  of variance . Data are recorded in 
Tab les  2 and 3 .  
Least- squares analys is of variance for P lan A indicated 
signi ficant (P (: 0 5) di fferences in treatment we�ght, ery­
throcyte ( RBC ) and plasma manganese , and di fferential 
leucocyte count ( lymphocyte , neutrophi l ,  monocyte, eos ino­
phi l  and basophi l ) . Weekly weight, hemoglobin concentration, 
PCV , MCV , MCH, MCHC , erythrocyte and plasma i ron , erythrocyte , 
plasma manganese , and differential count ( lymphocyte, neu­
trophi l and monocyte ) were di ffe_rent ( P  (. 0 5) • Week x 
treatment interaction indicated signi ficant ( P  (. 0 5) var­
iation for MCV , MCH , erythrocyte and plasma manganese . 
Least- squares analysi s  of variance for weeks f ive 
'!'ABLE 1. AVERAGE MEANS FOR WEEKS ONE, TWO, THREE AND FOUR. 
Basis Week Means Average S.E.a 
1 2 3 4· 
Weight (kg) 50.26 50.17 50.74 51. 59 50. 69 +· 7. 85 
-
Red Blood Cells x 106 7. 96 7.58 7.98 7.0 2 7.63 + 1.15 
(cubic millimeter) 
-




tration 12. 60 12. 58 12. 82 12. 77 12.69 + 1.91 
-
(grams/100 ml blood) 


















TABLE l CONTINUED 
Basis Week Means Average S . E . a 
1 2 3 4 
Red Blood Cell  Iron 1 0 3 7 . 8 4 1 0 0 7 . 6 0 9 8 8 . 5 8 1 0 3 1 . 0 6 1 0 16 . 2 7 + 1 4 9 . 39 
(micrograms/gram ( 
Plasma Iron 1 30 . 9 9 1 6 4 . 2 4 1 8 6 . 2 4 16 8 . 3 3 16 2 . 4 7 + . 4 1 
(micrograms/deciliter} 
-
Red Blood Ce ll  
Manganese 3 . 8 3 3 . 2 5  · 3 .  3 0  2 . 43 3 . 2 0  + 2 3 . 43 
(micrograms/gram) 
-
Plasma Manganese 4 . 0 2 2 . 7 8 2 . 0 0 2 . 0 0 2 . 7 0 + . 3 5 
(micrograms/liter )  
-
Lymphocyte Count 7 7 . 4 0  8 3 . 7 5  7 2 . 9 3 8 2 . 5 6 7 9 . 16 + 1 1 . 6 7 
(percent ) 
-
Monocyte Count 2 . 0 8 1 . 8 1  1 . 8 4  1 . 0 3 1 . 6 9  + 2 . 7 7 
(percent ) 
-
Neutrophil  Count is.SS 13 . 6 5 2 2 . 6 5 ·14 . 7 5 17 . 4 0  + . 2 9 
(percent ) 
-
Eosinophil Count 1 .  5 9  1 . 15 2 . 3 7 1 . 6 2  1 . 6 8 + . 2 9 
(percent ) 
-
Basophi l Count . 19 . 34 . 37 . 0 9 . 2 4 + . 0 6 
__i_Eercent ) 
-
astandard error . 
I\.) 
-...J 
TABLE 2 .  LEAST-SQUARES ANALYSIS OF VARIANCE , WEEKS ONE THROUGH NINE . 
Bas is Source d . f .  Sum o f  Squares Mean Squares F ratio 
Weight (kg ) Total 1 0 5  2 9 1 8 5 1 .  3 6 0  
Week 8 5 5 . 8 0 0  6 . 9 7 0  . 16 9  
Treatment 1 1 9 0 . 3 6 0  1 9 0 . 3 6 0  4 . 6 1 5 *  
Week x Treatmenta 8 2 7 6 . 3 5 0  3 4 . 5 4 0  . 8 3 8  
Remainderb 8 7  3 5 8 8 . 3 6 0  4 1 . 2 4 0  
Red Blood Cells Total 10 5 6 7 71 . 8 6 2  
Week 8 3 4 . 6 0 6 4 . 3 2 5  5 . 2 8 7 *  
Treatment 1 . 0 6 7  . 06 7  . 0 8 3  
Week x Treatmenta 8 1 1 . 7 4 8  1 . 4 6 8  1 . 7 9 5  
Remainderb 8 7 7 1 . 1 8 5  . 8 1 8  
White Blood Ce lls Total 1 0 5  1 4 1 . 0 1 4  
Week 8 . 6 4 6  . 0 8 0  1 . 4 9 3  
Treatment 1 . 16 3  . 0 2 3  3 . 0 19 
Week x Treatmenta 8 . 1 9 0  . 16 3  . 4 4 0  
Remainderb 8 7  4 . 7 0 7  . 0 5 4  
Hemoglobin Total 1 0 5  16 9 1 8 . 59 2  
Concentration Week 8 2 4 . 6 4 6  3 . 0 8 0  4 . 4 8 0* 
Treatment 1 . 9 6 9  . 9 6 9  1 . 4 1 0  
Week x Treatmenta 8 6 . 0 8 0  . 7 6 0  1 . 1 0 5  
Remainderb 8 7  5 9 . 8 2 8 . 6 8 7  
Packed Cell Total 1 0 5  1 9 0 19 3 . 8 2 0  
Volume Week 8 1 4 3 9 . 0 7 6  1 7 9 . 8 8 4  9 . 1 7 0 *  
Treatment 1 2 . 2 2 0  2 . 2 2 0  ' . 11 3  
Week x Treatmenta 8 i46 . 9 3 3  1 8 . 3 6 6  . 9 3 6  
Remainderb 8 7  . 1 7 0 6 . 7 2 4  1 9 . 6 17 f\J 
00 
TABLE 2 .  CONTINUED . . - . .. ... .. . . .. .... ... . .. .. . . .  ....... .  .. .. .. . . . . . .. .. -.. . 
Basis Source ... a. f. . .sum of .squares 
Mean Corpus- Total 10 5 3 2 3 1 6 1 . 8 4 1  
cular Volume Week 8 6 3 9 1 . 7 6 0  
Treatment • 1 . 9 0 4  
Week x Treatmenta 8 1 3-22 . 3 8 7  
Remainderb 8 7  5 4 9 8 . 2 3 1  
Mean Corpuscu- Total 1 0 5  2 8 0 6 8 . 2 6 1  
lar Hemoglobin Week 8 1 2 7 . 1 0 0  
Treatment 1 4 . 2 0 6  
Week x Tr5atmenta 8 9 3 . 8 9 5  
Remainder 8 7  3 1 2 . 4 3 0  
Mean Corpuscu- Total 1 0 5  9 8 8 9 7 . 4 5 4  
lar Hemoglobin Week 8 5 7 3 . 6 5 1  
Concentration Treatment 1 2 1 . 8 4 7  
Week x Treatmenta 8 4 0 . 6 8 5  
Remainderb 8 7  6 5 1 . 9 3 6  
Red Blood Cell Total 1 0 5  29 4 7 7 8 . 1 8 6  
Ircn Week 8 6 7 7 0 7 . 1 6 4  
Treatment 1 3 9 0 . 0 3 8  
Week x Treatmenta 8 1 6 6 0 9 . 3 9 8  
Remainderb 8 7  2 9 6 0 6 8 . 6 8 1  
Plasma· Iron Total 103 9 5 9 9 6 5 . 7 8 5  
Week 8 9 0 1 1 7 . 2 3 4  
Treatment 1 1 1 3 3 . 7 5 3  
Week x Treatmenta 8 5 9 7 2 . 1 0 4  
Remainderb 85 6 6 2 8 3 . 2 3 0  
Mean Squares F ratio 
7 9 8 . 9 7 0  1 2 . 6 4 2 * 
. 9 0 4  . 0 1 4  
1 6 5 . 2 9 8  2 . 6 1 6 *  
6 3 . 1 9 8  
1 5 . 8 8 7  4 . 4 2 4 *  
4 . 2 0 6  1 . 1 7 1  
1 1 . 7 3 6  3 . 2 6 8 * 
3 . 5 9 1  
7 1 . 7 0 6  9 . 5 6 9 *  
2 1 . 8 4 7  2 . 9 1 6  
5 . 0 8 5  . 6 7 9  
7 . 4 9 3  
846 3 . 3 9 5  2 . 7 3 7 *  
3 9 0 . 0 3 8  . 1 2 6  
2 0 7 6 . 1 7 4  . 6 7 1  
3 0 9 2 . 7 4 3  
11 2 6 4 . 6 5 4  1 4 . 4 4 5 *  
1 1 3 3 . 7 5 3  1 . 4 5 4  
7 4 6 . 5 1 3  . 9 5 7  
7 7 9 . 81 4  "' \0 
TABLE 2 .  CONTINUED. 
Basis Source 
Red Blood Cell Total 
Manganese Week 
Treatment 
Week x Treatmenta 
Remainderb 
Plasma Man- Total 
ganese Week 
Treatment 















Week x Treatrnenta 
Remainderb 
d. f .  









8 6  




8 7  




8 7  




8 7  
Sum o f  Squares Mean Squares F ratio" 
2 0 9 7 . 6 7 9  
1 0 7 . 6 2 3  1 3 . 4 5 2  6 . 4 9 0 *  
1 2 . 9 6 6  1 2 . 9 6 6  6 . 2 5 5 *  
1 3 4 . 0 9 4  1 6 . 7 6 1  8 . 0 8 6 *  
1 8 0 . 3 4 7  2 . 0 7 9  
5 7 4 2 . 4 0 0  
7 0 7 . 6 6 0  8 8 . 4 5 7  8 . 1 1 3 *  
3 1 5 . 4 6 6  · 3 1 5 . 4 6 6  2 8 . 9 3 5 * 
7 9 0 . 5 8 2  9 8 . 8 2 2  9 . 0 6 4 *  
9 3 7 . 6 2 4  10 . 9 0 2 . 
6 3 2 9 6 3 . 8 3 0 
2 1 6 7 . 2 2 7  2 7 0 . 9 0 3  2 . 5 0 9 *  
4 2 6 . 0 8 9  4 2 6  .. 0 8 9  3 . 9 4 5 *  
1 3 3 1 . 6 1 6  1 6 6 . 4 5 2  1 . 5 4 1  
9 3 9 5 . 4 8 5  1 0 7 . 9 9 4  
5 2 8 1 3 . 1 2 0  
1 7 3 1 . 4 1 3  2 1 6 . 4 2 6  2 . 1 9 8 *  
6 1 8 . 4 6 1  6 1 8 . 4 6 1  6 . 2 8 1 *  
1 4 2 8 . 2 0 0  1 7 8 . 5 2 5  1 . 8 1 3 *  
8 5 6 6 . 8 3 4  9 8 . 4 6 9  
6 6 5 . 8 4 0  
4 9 . 5 9 5 6 . 1 9 9  4 . 8 5 2 *  
. 5 . 4 4 2  5 . 4 4 2  4 . 2 6 0  
1 8 . 5 8 0  2 . 3 2 2  1 . 8 1 8  
111 . 1 5 3  1 . 2 7 7  w 0 















Week x Treatmenta 
Remainderb 
* Si gnificant ( P<. 0 5 ) . 
a = Week x treatment interaction. 
b = Source of error mean square . 





8 7  




8 7  
Sum o f  Squares 
3 8 2 . 110  
1 4 . 9 5 2  
9 . 1 2 3  
1 5 . 5 1 3  
10 8 . 4 5 2  
1 2 . 2 5 0  
1 . 3 7 1  
. 5 3 7  
. 2 9 4  
7 . 3 5 7  
Mean Squares 
1 . 8 6 9  
9 . 1 2 3  
1 . 9 3 9  
1 � 2 4 6  
. 1 7 1  
. 5 3 7  
. 0 3 6  
. 0 8 4  
F r a tio 
1 . 4 9 9  
7 . 3 1 9 * 
1 . 5 5 6  
2 . 0 2 7  
6 . 3 5 3 *  
. 4 3 5  
w 
...... 
TABLE 3 .  LEAST-SQUARES ANA!iY�IS : .<?F : ·\TARIANCE ,.  WEEKS FIVE THROUGH NINE • 
. 
Basis Source d . f. Sum of Squares Mean Squares F ratio 
Weight ( kg) Total 5 7  1 5 2 8 1 8 . 4 0 0  . 
Week 4 2 . 1 6 0  . 5 4.0 . 0 1 1  
Treatment 1 4 2 1 . 9 7 0  4 2 1 . 9 7 0  8 . 6 7 3 *  
Week x Treatmenta 4 3 3 . 9 3 0 8 . 4 8 0  . 1 7 4  
Remainderb 4 7  2 2 8 6 . 8 2 0  4 8  .. 6 5 0 
Red Blood · Cells Total 5 7  3 7 4 6 . 1 1 5  
Week 4 1 1 . 6 8 6  2 . 9 2 1  3 . 5 7 4 *  
Treatment 1 . 3 7 5  . 3 7 5  . 4 6 0  
Week x Treatmenta 4 2 . 3 4 2  . 5 8 5  • ·7 1 6  
Remainderb 4 7  3 8 . 4 2 2  . 0 6 5  
Wh ite Blood Cells Total 5 7  7 5 . 1 5 4  
Week 4 . 3 0 8  . 0 7 7  1 . 1 7 6  
Treatment 1 . 1 0 9  . 1 0 9  1 . 6 7 2  
Week x Treatmenta 4 . 0 9 1  . 0 2 2  . 3 5 1  
Remainderb 4 7  3 . 0 8 0 . 0 6 5  
Hemoglobin Total 5 7  8 6 6 9 . 6 7 3  
Concentration Week 4 7 . 0 3 4  1 . 7 5 8  2 . 0 4 1  
Treatment 1 . 5 2 0  . 5 2 0  . 6 0 4  
Week x Treatmenta 4 . 9 0 0  . 2 2 5  . 2 6 1  
Remainderb 4 7  4 0 . 4 9 0  . 8 6 1  
Packed . Cell Total 5 7  8 5 5 8 8 . 5 7 0  
Volume we·ek 4 5 6 . 6 5 0  1 4 . 1 6 2  . 7 1 9  
Treatment 1 5 9 . 3 2 5  5 9 . 3 2 5  3 . 0 1 3  
Week x Treatmenta 4 1 9 . 1 5 7  4 . 7 8 9  . 2 4 3  
Remainderb 4 7  9 2 5 . 3 1 8  1 9 . 6 8 7  
w 
N 
TABLE 3 .  CONTINUED . 
Basis Source 
Mean Corpus- Total 
cular Volume Week 
Treatment 
Week x Treatmenta 
Remainderb 
Mean Corpuscu- Total 
lar Hemoglobin Week 
Treatment 
Week x Treatmenta 
Remainderb 
. Mean Corpus cu- Total 
lar Hemoglobin Week 
Concentration Treatment 
Week x Treatmenta 
Remainderb 
Red Blood Cell Total 
Iron Week 
Treatment 
Week x Treatmenta 
Remainderb 
Plasma Iron Total 
Week 
Treatment 
Week x Treatmenta 
Remainderb 





4 7  




4 7  




4 7  









4 7  
Sum o f  Squares Mean Squares F rat i o  
1 3 6 0 4 8 . 6 2 6  
9 4 1 . 5 2 1  2 3 5 . 3 8 0  7 . 9 2 0 *  
2 0 4 . 8 2 6  2 0 4 . 8 2 6  6 . 8 9 2 * 
5 9 . 1 7 9  1 4 ·. 7 9 4  . 4 9 8  
1 3 9 6 . 7 8 5  2 9 . 7 1 8  
1 3 7 5 9 . 3 0 4  
3 4 . 5 � 7  8 . 6 4 9  3 . 5 9 4 *  
4 . 6 0 0  4 . 6 0 0  1 . 9 11 
9 . 1 3 8  2 . 2 8 4  . 9 4 9  
1 1 3 . 1 1 1  2 . 4 0 6  
5 9 6 4 3 . 7 5 4  
8 0 . 8 1 6  2 0 . 2 0 4  2 . 2 3 1  
2 6 . 2 4 7  2 6 . 2 4 7  2 . 8 9 8 
2 7 . 6 1 6  · 6 . 9 0 4  . 7 6 2  
4 2 5 . 6 8 1 9 . 0 5 7  
9 4 3 4 8 0 . 5 4 4  
1 7 8 2 4 . 4 4 8  4 4 5 6 . 11 2  2 . 0 0 1 
2 2 6 0 . 7 2 0  2 2 6 0 . 7 2 0  1 . 0 1 5  
1 3 4 9 1 . 4 8 0  3 3 7 2 . 8 7 0  1 . 5 1 5  
1 0 4 6 5 7 . 9 6 4  2 2 2 6 . 7 6 5  
7 2 0 5 0 2 . 8 2 2  
6 4. 11 . 8 7 8  1 6 0 2 . 9 6 9  1 . 8 5 3  
1 6 6 4 . 2 5 1  1 6 6 4 . 2 5 1  1 . 9 2 4  
. 8 2 8 . 0 8 2  2 0 7 . 0 2 0  . 2 3 9  
4 0 6 4 8 . 8 2 3  8 6 4 . 8 6 8  w w 
TABLE 3 .  CONTINUED. 
Basis Source 
Red Blood Cell Total 
Manganese Week 
Treatment 
Week x Treatmenta 
Remainderb 
Plasma Man- Totai 
ganese Week 
Treatment 















Week x Treatmenta 
Remainderb 
d . f .  




4 7  




4 7  




4 7  




4 7  




4 7  
Sum o f  Squares Mean. Squares F ratio 
--
1 7 0 7 . 1 9 2  
3 4 . 6 4 3  8 . 6 6 0  2 . 6 0 4 *  
7 8 . 2 4 2  7 8 . 2 4 2  2 3 . 5 2 0 *  
4 8 . 3 7 8  1 2 . 0 9 4  3 . 6 3 6 *  
1 5 6 . 3 5 1  3 . 3 2 6  
5 4 5 9 . 7 7 9  
4 9 6 . 1 7 8  1 2 4 . 0 4 4  6 . 2 9 3 *  
5 9 9 . 5 3 3  5 9 9 . 5 3 3  3 0 . 4 1 3 *  
4 9 0 . 8 4 6  1 2 2 . 7 1 1  6 . 2 2 5  
9 2 6 . 4 9 8  1 9 . 7 1 2  
3 2 5 3 9 8 . 0 9 0  
1 1 1 6 . 2 8 1  2 7 9 . 0 7 0  2 . 21 1 
9 7 6 . 5 0 0  9 7 6 . 5 0 0  7 . 7 3 5 *  
7 1 0 . 9 0 8  1 7 7 . 7 2 7  1 . 4 0 8  
5 9 3 3 . 5 3 0  1 2 6 . 2 4 5  
3 5 4 7 6 . 0 0 0  
9 11 . 8 8 1 2 2 7 . 9 7 0  1 . 9 7 5  
1 1 0 4 . 8 6 5  1 1 0 4 . 8 6 5  9 . 5 7 4 *  
7 9 0 . 6 9 4  1 9 7 . 6 7 3  1 . 7 1 3  
5 4 2 3 . 8 9 2  1 1 5 . 4 0 1  
4 6 9 . 0 0 0  
2 8 . 0 5 9 7 . 0 1 4  5 . 1 0 2 *  
2 . 3 0 2  2 . 3 0 2  1 . 6 7 4  
1 6 . 3 4 5  4 . 0 8 6  2 . 9 7 2 *  
6 4 . 6 2 5  1 . 3 7 5  w 
� 















Week x Treatmenta 
Remainderb 
* S ignificant (P(: O S } . 
a = Week x treatment interaction . 
b = Source of error mean square . 
d . f .  
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Sum of Squares 
1 8 9 . 5 0 0  
· 5 . 2 1 1  
5 . 5 3 7  
1 2 . 8 5 9 
5 9 . 4 3 7  
3 . 7 5 0  
. 4 1 7  
. 1 2 0  
. 11 3  
2 . 4 1 9  
Mean Squares 
1 . 3 0 2  
5 . 5 3 7  
3 . 2 1 4  
1 . 2 6 4  
. 1 0 4  
. 1 2 0  
. 0 2 8 . 
. 0 5 1  
F ratio 
1 . 0 3 0  
4 . 3 7 9 *  
2 . 5 4 2  
2 . 0 2 5  
2 . 3 4 1  




through nine indicated differences ( P (. 0 5) in treatment 
weight , MCV , erythrocyte manganese , plasma manganese , and 
diffe rential count ( lymphocyte , neutrophi l and eos inophi l ) ; 
also , weekly e rythrocyte ,. MCV , MCH , erythrocyte mangane se , 
plasma mangane se and differential monocyte . Week x treatment 
interaction of erythrocyte and plasma manganese  changed ( P(: O S ) . 
Mean wei ght of  principal sheep was lower than controls 
( figure 1) . Thi s may be due to dehydration of  principal 
animals  s ince the se animais did not eat or d rink regularly 
for a time fol lowing manganese admini s tration . S imi lar 
symptoms were observed by Hansard et a l . ( 1 9 6 0), $vaj gr et al . 
( 19 6 9 )  and Wade ( 19 7 2) .  One of the experimental sub j ects 
died fol lowing the second adminis tration o f  manganous 
chloride . 
Weekly variations in erythrocyte ( RBC ) concentration 
were pre sent in control and principal sheep ( figure 2), 
although contro l and principal subj ects erythrocyte 
concentrations did not change due to mangane se  inj ections . 
Since manganese administration in thi s  e xperiment was for 
a · short period of time ( 2  weeks ) , it is pos s ible that not 
enough time had e lapsed for mangane se to interfere with 
hematopo ie s i s . 
Least- square s analys i s  of variance o f  P lans A and B 
did not indicate differences be tween control and principal 
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Weeks one through nine analysis  o f  variance o f  hemo­
globin concentration indicat.ed week ly changes ( P (. 0 5 )  . . 
However ,  mean hemoglobin concentration o f  principal sheep 
was not di f ferent than that of controls . Thi s i s  in  
accordance wi th . findings of  Ci zadlo ( 1 9 7 2 ) . Ruminants have 
a high concentration of body iron . I t  i s  pos s ible that the 
small  amount o f  mangane se admini strated i n
.
thi s  experiment 
could not alte r  the large iron pool . There fore , less  
comp�tition by  manganese with iron for  hemoglobin synthesis  
occurred� A s te ady decline in hemoglob in concentration was 
seen in both principal  and control anima l s  through the 
course o f  the experiment ( figure 4 ) . Weekly cha�ges ( P (. 0 5 )  
were seen in packed cel l  volume ( figure 5 ) . Mean PCV of 
principal sheep did not differ  from contro l s . Thi s  agreed 
with findings of Robinson ( 1 9 6 0 ) . 
P lan B s tati s tical analysis  of MCV indicated that mean 
MCV of principa l  sheep was les s  than that of controls 
( figure 6 ) . Thi s  could not be re lated to the e ffects of 
manganese  on internal structural components of erythrocytes  
(RBC ) s ince hemoglobin concentration , PCV , and erythrocyte 
concentration did not increase or decrease a s  a result of  
experimental treatments . Depres sed MCV i n  principal sheep 
may be due to dehydration after manganese  adminis tration .  
Dehycfr�tion would remove intrace llular. f luids from 
erythrocytes . Also , decreased MCV may be attributed to 
a 
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w 
. increased extrace llular and interstitial manganese con-
centration , because increased solute concentration in 
plasma portion of  blood could cause water e ff lux . There 
were also weekly variations in MCV ( P(.  0 5 ) . 
MCH and MCHC did not change due to manganese admini s-
' 
tration ( figures 7 and 8 )  . Weekly variations of MCH and 
MCHC were seen ( P (. 0 5 ) . 
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No di f fe rence s were seen between contro l and principal 
sheep mean erythrocyte and plasma iron concentrations 
( figures 9 and 1 0 ) : However ,  erythrocyte i ron con.centrations 
general ly increased and plasma iron concentration decreased . 
Erythrocyte manganese  ( figure 1 1 )  increased ( P  <_: 0 5 ) 
after mangane se adminis tration . The se resul ts are in 
agreement with s tudies of  Cizadlo ( 1 9 7 2 ) , Kerr ( 1 9 7 5 )  and 
in vi tro s tudie s of  Weed and Rothste in ( 1 9 6 0 ) . I t  should 
be noted that in a mature erythrocyte mangane se cannot 
replace i ron in the heme molecule ; it mus t  then bind to 
some other intrace l lular structure such as ATP or enolase 
(Weed and Rothstein , 1 9 6 0 ) . 
Plasma mangane se increased five fold after the second 
mangane se inj ect�on ( P � OS ) . However ,  a rapid decrease in 
plasma mangane se leve ls at weeks seven , e ight , and nine were 
seen ( fi gure 1 2 ) . Thi s  suggests that manganese i s  · dis tribu­
ted rapid ly into tis sues and does not remain - in the plasma 
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work reported b y  Borg and Cotzias ( 1 9 5 8 )  which indicated 
that radiomangane se di s appears rapidly from the b loods tream.  
Least- squares analys i s  of variance of lymphocyte , 
eos inophi l  and basophil  counts for weeks one through nine 
were depre s sed , wh� le neutrophil  and monocy te counts 
increased ( P � O S )  ( figures 1 3- 17 ) . Decreas ed eos inophil  
and basoph i l  counts and increased rnonocyte �ounts  are not 
in agreement wi th re sults of Kesic  and Haus ler ( 1 9 5 4 ) . 
Thes� authors found depre s sed monocyte and increa sed 
eosinoph i l  and basophil  values in miners  e xposed to manganese 
dust .  Increased neutrophil counts may be attributed to its 
function in po isoning ( Guyton , 1 9 7 1 ) . S ince manganese 
adminis tration caused toxicity , neutrophi l  counts increased . 
Decreased lymphocyte counts , also may be re l ated to the 
increase in neutrophil  counts ; in emergency cas es , 
lymphocyte s de-differentiate and re-di fferentiate into any 
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SUMMARY 
Mangane se , one of  the trace e lements o f  the transition 
group , has been known to be es sential in animal nutrition 
since 1 9 2 6 . 
Exce s s ive dietary mangane se in growing mammal s  have 
depre ssed hemoglobin formation and growth . Although 
manganese toxi city has not been reported under normal 
condi tions , miners working with mangane se dus t have 
deve loped mangane se toxicity . 
Since effects of manganese intoxication in normal , 
healthy sheep have not be�n thoro�ghly inve s ti gated , these 
investigations were designed to provide information con­
cerning ma�gane se intoxication in ruminants . 
Twe lve Cross -Finn sheep were uti li zed in these  studies . 
Animals  were randomly as signed to control and treatment 
. groups . Both contro l and principal groups were bled for 
four consecutive weeks without manganese adminis tration .  
Duri�g weeks five and
.
s ix ,  the treatment group rece ived in­
j ections of s �g Mn/kg of body weight , whi le the control group 
was i�j ect with phys iological saline . Effects of pos t­
ma�gane se toxicity were observed during weeks seven , eight 
and nine .  
Blood s ample s  were obtained after we ighing each animal 
every week . Erythrocyte and leucocyte counts were obtained 
electroni cal ly . Also measured were packed ce l l  volume , 
5 8  
hem�globin concentration , Wintrobe indice s , differential 
leucocyte counts , erythrocyte and plasma iron and manganese 
concentrations . 
Col lected data were analyzed by the least- squares 
analy s i s  of  variance . Least-square s analys i s  o f  variance 
for weeks one through nine indicated s igni f icant ( P( . 0 5 )  
di fferences in treatment we ight , erythrocyte ( RBC )  and 
plasma manganese , and differentia l leucocyte count ( lymph­
ocyte , neutroph i l , monocyte , eos inophi l and basophi l ) .  · Also 
week ly we ight , hemoglobin concentration , PCV , MCV , MCH , 
MCHC , erythrocyte and plasma iron , erythrocyte and plasma 
mangane se , a lso differential count ( lymphocyte , neutrophil , 
and monocyte ) were different ( P{ . 0 5 ) . Week x treatment 
interaction also indicated significant ( P( . 0 5 )  variation 
for MCV , MCH , erythrocyte and plasma manganese . 
Leas t- squares analys is of variance for weeks five 
through nine indicated dif ferences ( P( . 0 5 )  in treatment 
weight , MCV , erythrocyte manganese , p la sma manganese , 
�nd . differentia� count ( lymphocyte ,  neutrophil  and 
eosinophi l ) ;  also , week ly erythrocyte , MCV , MCH , erythrocyte 
ma�ganese , pla�ma mangane se and di fferential monocyte . 
Week x treatment erythrocyte and plasma manganese changed 
(P( . 0 5 ) . 
5 9  
Manganese  admini stration i n  a short period ( 2  weeks ) did 
not alter hemoglobin synthesis , PCV , and erythrocyte 
concentration in s heep . Probab ly not enough time e lapsed 
for mangane se to interfere with hematopoiesi s ,  and hemo­
globin synthe s i s . Also  the fac t that no changes were ob­
served may be due to high iron body pool of ruminants .  
MCV decreased in principal groups , a lthough this 
depres s ion could not be re lated to direct e f fects of 
mangane se on the erythrocyte structural components . �h1 s 
depre s s ion might have been due to dehydration , or increase 
in ions in extrace l lular fluid portion of  the blood . 
There was an increased manganese uptake by erythrocyte . 
However , the s ite of manganese attachment in the erythrocyte 
was not investigated . It  is  possible that  these  ions were 
bound to s troma or some intrace llular components o f  
erythrocyte . Further investigations concierning the s ite of 
manganese in mature erythrocyte are needed . 
Plasma manganese levels  increased rapidly after  man-
. 9anese adminis tration . P lasma manganese leve l s  decreased 
after rna�gane se in j ections were discontinued , as manganese 
Was probably transported to the tissues and/or excreted 
into feces . 
Erythrocyte iron and plasma iron did not change in 
control and principal group following manganese  ad­
ministration . 
D i f fe r e nt i a l  lympho cyte count was d e c r e a s e d  and 
ne ut roph i l count i nc reas e d . The s e  change s could be due to 
the body repon s e  to mangane s e  intox i c a t i on . 
De c re a s ed body we ight in princ ipa l group was probably 
due to dehydration fo l lowing mangane s e  i n j e c t ions . 
6 0  
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APPENDIX 
RAW DATA 
· TABLE ·1 WEEK 1. 
Group Weight RB Ca WBCb Hbc PCV% Mcvd MC He MCHCf 
kg 
Control 
1 5 0 . 9 1 8 . 1 6 1 . 3 1 1 1 . 6 0 4 0 . 0 0 4 9 . 0 2 1 4 . 2 2  2 9 . 0 0 
2 4 0 . 4 5  7 . 7 6 1 . 1 8 11 . 5 0 5 0  . . 0 0 6 4 . 4 3 1 4 . 8 2 2 3 . 0 0 
3 5 2 . 7 3 6 . 8 3 1 . 4 0 1 2 . 8 0 5 2 . 0 0 7 6 . 1 3 1 8 . 7 4 2 4 . 6 1  
4 5 5 . 0 0  11 . 2 0 1 . 2 2 1 2 . 5 0 4 3 . 0 0 3 8 . 3 9 1 1 . 1 6  2 9 . 0 7 
Treatment 
1 5 5 . 0 0  9 . 1 1 1 . 2 8 1 4 . 0 0 5 0 . 0 0 5 4 . 8 8 1 5 . 3 7  2 8 . 0 0  
2 5 1 . 3 6  7 . 8 7 1 . 0 3 1 3 . 3 0 5 5 . 0 0 6 9 . 8 9 1 6 . 9 0 2 4 . 1 8 
3 5 2 . 7 3 6 . 2 3 1 . 4 3 1 2 . 9 0 5 3 . 0 0  8 5 . 0 7  2 0 . 7 1  2 4 . 3 4  
4 5 7 . 2 7 6 . 5 9 1 . 4 7 11 . 9 0 4 8 . 0 0 7 2 . 8 4 1 8 . 0 6  2 4 . 7 9 
5 4 6 . 3 6 6 . 6 4 1 . 3 1 1 2 . 9 0 4 4 . 0 0 6 6 . 2 7 1 9 . 4 3 2 9 . 3 2 
6 4 7 . 7 3 5 . 2 9 1 . 5 1 1 4 . 3 0  5 1 . 0 0 9 6 . 4 1 2 7 . 0 3 2 8 . 0 4 
7 5 1 . 3 6 4 . 6 6 1 . 0 6 12 . 7 0 5 0 . 0 0 1 0 7 . 3 0 2 7 . 2 5 2 5 . 4 0  
8 4 2 . 7 3 7 . 1 1 1 . 1 5 1 2 . 5 0 4 0 . 0 0 5 6 . 2 6  1 7 . 5 8 31 . 2 5 
aRBC x 10 6 /mm3 . 
bwBc x io 4;mm3 . 
CHb g/10 0 ml . 
dMean Corpuscular Volume . 
eMean Corpuscular Hemoglobin . 
fMean Corpuscular Hemoglobin Concentration . O"I -..J 
RAW DATA 
TABLE 1 WEEK 1 CONTINUED 
Group Plasma Red blood cells Differential· countsh 
Fe ug/dl Mn ug/l Fe ug/g Mn ug/g ·1ym · neutro mono eos in baso 
Control 
1 1 4 0 . 5 3 . 8 0 9 8 2 . 6 0  5 . 0 0 0  8 9 . 5 0  1 1 . 5 0  2 . 0 1 . 5 • 0 
2 17 5 . 8 2 . 0 0 9 3 9 . 1 3 4 . 0 5 2  8 4 . 5 0 1 2 . 0 0 1 . 5 1 . 0 1 . 0 
3 1 9 1 . 5 5 . 0 0 1 0 8 6 . 9 6 3 . 9 3 2  7 9 . 0 0 1 7 . 5 0 1 . 5 1 . 5 . 5 
4 1 7 3 . 5  2 . 0 0 1 0 2 6 . 0 8 3 . 2 2 0  7 5 . 0 0  2 2 . 5 0 . 5 1 . 5  . 0 
· Treatment 
1 1 6 4 . 8  2 . 0 0 9 5 6 . 5 2 2 . 9 6 6  9 2 . 5 0  5 . 5 0 1 . 5 1 . 5 . 0 
2 1 5 7 . 8  2 . 0 0 9 9 1 . 3 0 2 . 0 6 9  9 3 . 5 0  3 . 5 0 • 5 3 . 0 . 0 
3 1 7 7 . 8  2 . 4 0 8 7 8 . 2 6 1 . 4 8 3  8 5 . 0 0 1 2 . 5 0 2 . 5  . 5 . 0 
4 1 2 8 . 2 2 . 0 0 1 0 4 3 . 4 8  2 . 2 4 1  9 5 . 5 0 2 . 0 0 2 . 0  • 0 • 5 
5 i i 1 0 5 2 . 1 7 2 . 7 8 0  8 3 . 0 0  1 3 . 5 0 3 . 0 • 0 • 5 
6 1 3 9 . 3  2 . 6 4 1 0 5 2 . 1 7 3 . 3 9 0  7 5 . 5 0 2 2 . 5 0  • 5 1 . 5 • 0 
7 1 7 7 . 9  3 . 6 0 1 0 6 9 . 5 6 2 . 3 7 3 8 9 . 0 0 7 . 0 0 3 . 5  • 0 . 5 
8 16 1 . 4  2 . 0 0 1·0 0 8 . 6 9  2 .  4 4 1  . ·7 0 .  0 0  2 5 . 0 0  4 . 5· · ·1 .  0 • 0 
hPercentage of 2 0 0  counts of lymphocytes , neutrophils , monocytes , eos inophils and 
basophils . 




TABLE 1 WEEK ·2 
Group Weight RB Ca WBCb Hbc PCV% Mcvd MC He MCHCf 
kg 
Control 
1 5 0 . 9 1 7 . 8 7 1 . 2 8 1 2 . 6 2 4 3 . 0 0  5 4 . 6 4  1 6 . 0 4 2 9 . 3 5 
2 4 0 . 9 1 7 . 9 5 1 . 1 4 1 1 . 3 8 4 0 . 0 0 5 0 . 3 1  1 4 . 3 1  2 8 . 4 5  
3 5 4 . 5 5 8 . 1 0 0 . 8 9 1 3 . 4 4 5 1 . 0 0 6 2 . 9 6  1 6 . 5 9 2 6 . 3 5  
4 5 4 . 5 5 a . 0 2 1 . 1 5 1 2 . 5 1  4 4 . 5 0 5 5 . 4 9 1 5 . 6 0  . 2 8 . 1 1 
Treatment 
1 5 6 . 3 6 8 . 9 9 1 . 10 1 4 . 4 3 4 9 . 0 0 5 4 . 5 1 1 6 . 0 5 2 9 . 4 5 
2 4 9 . 0 9 8 . 5 3 . 8 9 1 3 . 5 7  4 9 . 0 0 5 7 . 4 4 1 5 . 9 1 2 7 . 6 9 
3 5 4 . 0 9 7 . 4 2 . 9 5 1 2 . 5 7  4 2 . 5 0 5 7 . 2 8 1 6 . 9 4 2 9 . 5 8 
4 5 8 . 6 4 8 . 2 4 1 . 0 9 1 2 . 6 4 5 5 . 0 0 6 6 . 7 5  1 5 . 3 4 2 2 . 9 8 
5 4 7 . 7 3 7 . 3 3 1 . 6 3 1 3 . 6 3 4 9 . 0 0 - 6 6 . 8 5  1 8 . 5 9 2 7 . 8 2 
6 4 7 . 7 3 8 . 4  . 9 4 1 3 . 0 7 5 0 . 5 0 6 0 . 1 2 1 5 . 5 6 2 5 . 8 8 
7 5 2 . 2 7 7 . 5 8 1 . 2 1 1 2 . 6 9 5 2 . 5 0 6 9 . 2 6  1 6 . 7 4 2 4 . 1 7 
8 4 4 . 0 9 7 . 4 6 1 . 0 6 1 2 . 6 2 4 2 . 0 0 5 6 . 3 0  1 6 . 9 2  3 0 . 0 5 
aRBc · x lo 6;mm3 . 
bwBc x lo 4/mm3 . 
CHb g/1 0 0  ml . 
dMean Corpuscular Volume . 
eMean Corpuscular Hemoglobin . 
fMean Corpuscular Hemoglobin Concentration . °' \.0 
RAW DATA 
TABLE 1 WEEK 2 CONTINUED 
Group Plasma Red blood cells  Di fferential countsh 
Fe ug/dl Mn ug"/l Fe ug/g Mn ug/g · · lym · ne·utr·o mono eos in baso 
Control 
1 1 6 2 . 6  2 . 0  1 0 4 3 . 4 8 3 . 9 2 5  6 9 . 0 0  2 5 . 5 0  1 . 5  4 . 0  . 5 
2 2 6 5 . 4 2 . 0  10 0 0 . 0 0 4 . 4 4 4  7 1 . 5 0  2 2 . 0 0 2 . 0  3 . 5  1 . 0 
3 17 0 . 6 i 2 . 0  1 0 0 0 . 0 0 4 . 3 0 6  6 8 . 5 0  3 0 . 0 0 1 . 0 2 . 5  • 0 4 2 . 0 9 0 4 . 3 5 3 . 0 9 6  7 8 . 0 0  1 6 . 5 0  3 . 0 2 . 0 . 5 
. Treatment 
1 2 0 2 . 4  2 . 0 1 0 0 0 . 0 0 2 . 0 4 9  7 9 . 5 0 1 5 . 0 0  2 . 5 1 . 5 1 . 5 
2 1 6 7 . 4  2 . 0 1 0 6 0 . 8 7 3 . 3 5 6  8 4 . 0 0 1 3 . 5 0  1 . 5 1 . 0 . 0  
3 1 3 1 . 8 2 . 0  1 0 8 6 . 9 6 3 . 8 4 8  6 1 . 0 0 3 4 . 0 0 2 . 0 3 . 0 • 0 
4 2 1 5 . 2  2 . 0 8 6 0 . 8 7 2 . 4 3 1 8 3 . 5 0  1 3 . 0 0  2 . 5  1 . 5 • 0 
5 1 8 0 . 2  2 . 0  9 6 5 . 2 2  2 . 2 6 9  6 5 . 0 0  3 1 . 0 0 2 . 5 1 . 0 . 5 
6 1 5 4 . 6  2 . 0  9 7 3 . 9 1 4 . 3 9 8  8 0 . 0 0 17 . 5 0  • 5 2 . 5  • 0 
7 1 8 1 . 4  2 . 0  10 4 3 . 4 8  1 . 6 2 0  8 1 . 5 0 17 . 0 0 1 . 5 . 5 . 0  
8 1 5 2 . 2 2 . 0 9 3 0 . 4 3 1 . 3 3 9 5 8 . 5 0 37 . ·o O' ·1 .  5· · 3 .  0 . 0 
hpercentage of 2 0 0 counts of lymphocytes , neutrophils , monocytes , eosinophils and · 
basophils . 




TABLE 1 WEEK 3 
Group Weight RBca WBCb Hbc PCV% Mcvd MC He MCHCf 
kg 
Control 
1 5 1 . 8 2 6 . 7 8 . 7 2 1  1 1 . 9 9 5 2 . 0 0 7 6 . 7 0  1 7 . 6 8 2 3 . 0 6  
2 4 2 . 2 7 7 . 0 7 . 8 3 5  1 2 . 4 1 4 6 . 5 0 6 5 . 7 7 1 7 . 5 5 2 6 . 6 9 
3 5 4 . 4 5  6 . 4 6 1 . 1 9 0  1 2 . 4 4 4 4 . 0 0 6 8 . 1 1 1 9 . 2 6 2 8 . 2 7  
4 5 6 . 3 6 6 . 9 8 1 . 3 0 0  1 2 . 6 9 4 3 . 0 0 6 1 . 6 0 1 8 . 1 8 · 2 9 . 5 1 
Treatment 
1 5 6 . 3 6  7 . 8 1 1 . 0 0 0  1 4 . 1 7  5 0 . 0 0 6 4 . 0 2  1 8 . 1 4  2 8 . 3 4  
2 5 0 . 4 5 6 . 8 5 1 . 4 0 0  1 2 . 3 1 4 8 . 00 7 0 . 0 7 1 7 . 9 7 2 5 . 6 5  
3 5 3 . 6 4  6 . 8 8 1 . 2 6 0  1 2  .. 8 6  4 5 . 0 0 6 5 . 11 1 8 . 6 9  2 8 . 5 8 
4 5 9 . 5 5  7 . 3 3 1 . 2 7 0  1 2 . 7 6 5 0 . 00 6 8 . 2 1  1 7 . 4 1 2 5 . 5 2  
5 4 8 . 6 4  7 . 6 0 1 . 3 7 0  1 3 . 6 4 51 . 50 · 6 7 . 7 6 1 7 . 9 5 2 6 . 4 9 
6 4 7 . 2 7  7 . 4 8 1 . 1 3 0  1 4 . 0 1 5 0 . 0 0 6 6 . 8 4  1 8 . 7 3 2 8 . 0 2  
7 5 3 . 1 8 7 . 1 5 1 . 1 7 0  1 3 . 3 5  4 9 . 00 6 8 . 5 3 1 8 . 6 9  2 7 . 2 4 
8 4 4 . 5 5 6 . 6 6 1 .  2 2 0  1 2 . 2 2 4 1 . 00 6 1 . 5 6 1 8 . 3 5 2 9 . 8 0 
aRBc· x l0 6/nun3 . 
bwBc x l o 4;mm3 . 
CHb g/1 0 0  ml . 
dMean Corpus cular Volume . 
eMean Corpus cular Hemoglobin . 
fMean Corpus cular Hemoglobin Concentration . ....J ,_, 
RAW DATA 
TABLE" 1 WEEK 3 CONTINUED 
Group Plasma ;Red blood ce lls  Differential countsh 
Fe ug7dl Mn ug71 Fe ug7g Mn ug7g Tyrn · neutro mono �osin baso 
Control 
1 1 2 9 . 8  2 . 0  1 0 5 5 . 1 2 3 . 1 3 3  7 5 . 5 0  2 1 . 0 0 . 0  3 . 0 . 5 
2 1 5 4 . 4  2 . 0 10 7 8 . 7 9 3 . 6 7 5  8 3 . 0 0  1 2 . 5 0  1 . 5 3 . 5  . 0  
3 1 6 5 . 4 2 . 0 10 6 2 . 9 9 3 . 1 3 3  9 1 . 0 0 8 . 0 0 . 0 1 .  0 • 0 
4 1 6 4 . 8  2 . 0 8 9 7 . 6 3 2 . 6 1 1  8 2 . 5 0  1 6 . 5 0  . 5  • 5 . 0 
. Treatment 
1 1 7 9 . 9  2 . 0 1 0 7 0 . 8 7 1 . 6 8 7 7 7 . 5 0  1 8 . 5 0  2 . 5  4 . 5 . o  
2 1 8 1 . 2 2 . 0  1 0 6 2 . 9 9 1 . 5 6 6  7 6 . 0 0 2 1 . 5 0 1 . 5 . 5  • 5 
3 1 4 2 . 0  2 . 0  1 1 2 6 . 9 8 2 . 0 4 8  8 5 . 5 0  1 3 . 0 0  1 . 0 . 5 . 0 
4 2 2 3 . 8 2 . 0 9 6 8 . 50 . 9 6 4  8 9 . 5 0  9 . 5 0 1 . 5 . 0 . 0 
5 1 8 5 . 0  2 . 0 1 0 39 . 3 7 . 6 8 7  9 1 . 5 0  6 . 0 0 3 . 5 . 0 • 0 
6 21 4 . 6  2 . 0  1 0 0 0 . 0 0 3 . 2 0 5  9 0 . 0 0 8 . 5 0 1 . 0 • 5 • 0 
7 19 3 . 4  2 . 0  10 31 . 9 9 1 . 16 9  8 5 . 0 0 6 .  5 0  . 1 . 5  3 . 0 . 0  
8 1 4 4 . 6  2 . 0 1 0 0 7 . 8 7 2 . 4 7 0  . . "65 . 5 0  39 . so· · . 0 l· . 0 • 0 
hPercentage of 2 0 0  counts of  lymphocytes ,  neutrophils , monocytes , eos inophils and 
basophils . 




TABLE 1 WEEK 4 
Group Weight RB Ca WBCb Hbc PCV% Mcvd MC He MCHCf 
kg 
Control 
1 · s 1 . 8 2  9 . 8 0 1 . 1 1 1 2 . 5 5  3 7 . 5 0 3 8 . 2 7  1 2 . 8 1 3 3 . 4 7 
2 4 1 . 3 6  7 . 8 8 1 . 0 0  1 3 . 4 2 4 5 . 0 0 5 7 . 1 1 1 7 . 0 3 2 9 . 8 2  
3 5 5 . 0 0  9 . 3 7 . 8 9 1 4 . 3 9 4 8 . 5 0 5 1 . 7 6 1 5 . 3 6  2 9 . 6 7  
4 5 4 . 4 5 8 . 8 9 1 . 0 6 1 3 . 5 6 4 2 . 0 0 4 7 . 2 4 
. 1 5 . 2 .5 3 2 . 2 9 
Treatment 
1 5 6 . 3 6  8 . 5 5 1 . 5 5 1 4 . 2 9 4 7 . 0 0 5 4 . 9 7  1 6 . 7 1  3 0 � 4 0  
2 5 0 . 9 1 9 . 1 0 . 6 1 1 4 . 2 5 4 4 . 0 0 4 8 . 3 5  1 5 . 6 6 3 2 . 3 9  
3 5 3 . 1 8  8 . 17 . 9 1 1 3 . 4 5 4 0 . 5 0 4 9 . 5 7  1 6 . 4 6 3 3 .  2 1 . 
4 5 9 . 0 9 9 . 1 2 1 . 12 . 1 3 . 3 1  4 4 . 0 0 4 8 . 2 5  1 4 . 5 9  3 0 . 2 5 
5 4 8 . 6 4  9 . 8 6 1 . 10 1 4 . 5 7 4 8 . 0 0 4 8 . 6 8  1 4 . 7 8 3 0 . 3 5 
6 4 7 . 2 7 9 . 6 7 1 . 2 6  1 4 . 7 0 4 3 . 0 0 4 4 . 4 7 1 5 . 2 0 3 4 . 1 8 
7 5 4 . 5 5 9 . 0 8 1 . 1 8 1 3 . 3 1  4 1 . 0 0 4 5 . 1 5 1 4 . 6 6  3 2 . 4 6  
8 4 3 . 6 4 8 . 8 2 . 8 9 1 3 . 28 3 5 . 0 0 3 9 . 6 8  1 5 . 0 6 3 7 . 4 9 
aRBC x 1 0 6/mm3 . 
bwBC x io 4/mm3 . 
CHb g/1 0 0  ml . 
dMean Corpuscular Volume . 
eMean Corpuscular Hemoglobin . 
fMean Corpuscular Hemoglobin Concentration . ....J VJ 
RAW DATA 
TABLE 1 WEEK 4 CONTINUED 
Group Plasma Red blood cells  · · · · · Di ff·e·rentia·1 countsh 
Fe ug7dl Mn ug71 · Fe ug/g Mn ug/g ·1yrn · ·netrtro· · ·mono eos in baso 
Control 
1 11 1 . 4 0 3 . 0 0 9 7 0 . 9 5 3 . 5 1 9  9 2 . 0 0 6 . 0 0 . 0 2 . 0 . 0 
2 9 7 . 9 0 3 . 7 7 10 9 5 . 4 3 3 . 5 3 2  6 9 . 3 0  2 5 . 2 0  2 . 5 2 . 5  . 5 
3 1 3 5 . 9 0 3 . 0 3 1 0 9 5 . 4 3 2 . 8 4 6  7 3 . 0 0  2 4 . 0 0 1 . 5 1 . 5  • 0 
4 1 2 9 . 7 0 2 . 0 0 10 3 7 . 3 4 2 . 9 8 6  7 6 . 5 0  1 9 . 0 0 2 . 5  3 . 5 • 0 
Treatment 
1 1 2 5 . 0 0 2 . 8 6 9 7 0 . 9 5 2 . 0 3 7 7 0 . 5 0  2 6 . 0 0 • 5 2 . 5 • 5 
2 1 4 3 . 7 5 3 . 0 9 9 9 5 . 8 5 1 . 6 5 2  9 3 . 5 0 3 . 0 0 1 . 5 2 . 0 . 0  
3 1 1 5 . 1 0 2 . 8 6 1 1 5 3 . 5 2 2 . 3 8 9 6 6 . 0 0  2 6 . 9 0 4 . 7  1 . 9 . 5  
4 1 4 4 . 9 0 2 . 0 0 10 2 9 . 0 4 1 . 2 7 1  9 4 . 0 0 4 . 0 0 1 . 0 1 . 0 . o  
5 1 2 7 . 10 2 . 4 0 10 7 8 . 8 3  1 . 19 4  6 6 . 0 0  3 1 . 5 0 2 . 0  • 5 . 0  
6 1 6 6 . 7 0 2 . 8 0 10 9 5 . 4 3 3 . 6 8 5  7 4 . 0 0 2 0 . 0 0  2 . 5 3 . 5 . 0 
7 1 4 6 . 4 0 3 . 0 3 1 1 1 2 . 0 3 1 . 4 6 1  8 4 . 0 0  1 3 . 5 0  1 . 0 1 . 5 . 0 
8 10 6 . 3 0 2 . 9 0 ·1 0 7 0 . 5 4  i· . 3 2 1  7 5  . ·o o  2 0 . 5 0  2 . 5  2 . 0  • 0 





TABLE 1 WEEK 5 
Group Weight Rae a wacb Hbc PCV% Mcvd MC He MCHCf 
kg 
Control 
1 5 1 . 8 2 · 8 . 1 3 1 . 1 5 1 2 . 7 1 3 6 . 0 0 4 4 . 2 8 1 5 . 6 3 3 5 . 31  
2 4 1 . 3 6 7 . 8 8 1 . 1 5 1 3 . 5 8  4 1 . 0 0  5 2 . 0 3 1 7 . 2 3 3 3 . 1 2  
3 5 5 . 0 0 9 . 3 5 1 . 2 4 1 3 . 0 6 4 1 . 0 0  4 3 . 8 5  1 3 . 9 7  3 1 . 8 5 
4 5 6 . 3 6  -8 .  5 6  1 . 2 9 1 2 . 0 4 3 7 . 0 0 4 6 . 3 1  1 5 . 0 7 3 2 . 5 4  
Treatment 
1 5 3 . 1 8  8 . 8 9 1 . 2 7 1 3 . 5 3 3 8 . 0 0 4 2 . 7 4 1 5 . 2 2 3 5 . 6 1  
2 4 8 . 6 4  8 . 0 3 1 . 1 2 1 3 . 1 4  3 9 . 0 0 4 8 . 5 7  16 . 3 6 3 3 . 6 9  
3 5 0 . 0 0 7 . 0 3 1 . 0 7 1 2· . 0 7  3 7 . 0 0 5 2 . 6 3 1 7 . 1 7 3 2 . 6 2 
4 5 5 . 9 1  8 . 4 5 1 . 3 6 1 2 . 8 2 4 0 . 0 0 4 7 . 3 4  1 5 . 1 7 3 2 . 0 5 
5 4 4 . 0 9  1 1 . 2 1 1 . 19 1 3 . 4 9 3 9 . 0 0 3 4 . 7 9 1 2 . 0 3 3 4 . 5 9  
6 4 3 . 1 8 8 . 8 8 1 . 3 3  1 3 . 9 3 4 0 . 0 0 4 5 . 0 5 15 . 6 9 3 4 . 8 3  
7 51 . 3 6 8 . 5 9 1 . 1 4 11 . 9 8 3 4 . 5 0 4 0 . 1 6  1 3 . 9 5 3 4 . 7 2 
8 4 1 . 3 6 8 . 2 5 1 . 4 9 11 . 7 7 3 4 . 5 0 4 1 . 8 2 1 4 . 2 7 3 4 . 1 2 
aRBC x 10 6/mm3 . 
bwBc x l o 4;rcun3 . 
CHb g/1 0 0  ml . 
dMean Corpuscular Volume . 
eMean Corpuscular Hemoglobin . 

















TABLE l· WEEK 5 CONTTNUED · . . . . . .  . . 
Plasma Red bl·o·od cells  D iffer·ential ·countsh 
Fe ug7dl Mn ug71 Fe ug7g Mn ug7g· ·1yrn neutro · mon·o eos in 
1 0 9 . 2  2 . 0 0 1 0 5 8 . 8 2 3 . 8 0 1  6 7 . 0 0  2 2 . 0 0  5 . 0 6 . 0  
1 4 0 . 8  2 . 0 0 1 0 5 0 . 4 2 4 . 7 5 9  7 0 . 0 0 2 0 . 5 0  4 . . 5 4 . 5  
1 0 3 . 1  2 . 0 0 1 0 7 5 . 6 3 2 . 7 8 5  7 7 . 5 0  1 7 . 5 0 4 . 0  1 . 0 
7 9 . 7  2 . 0 0 1 0 2 5 . 2 1 3 . 7 5 8  9 2 . 0 0  6 . 0 0 2 . 0  . 0 
9 9 . 7  1 4 . 3 0 1 0 5 8 . 8 2 3 . 8 0 1  7 8 . 0 0 1 8 . 5 0 3 . 0  . 5  
1 5 5 . 5  1 2 . 5 0  1 0 9 2 . 4 4 3 . 7 7 8  7 2 . 0 0  2 5 . 0 0 2 . 0 1 . 0 
1 0 4 . 4  6 . 9 0 1 1 2 6 . 0 5 2 . 6 1 4  6 5 . 0 0 2 9 . 0 0  3 . 0 3 . 0 
1 7 6 . 4  7 . 1 0 1 0 0 0 . 0 0 2 . 5 5 7  7 5 . 0 0 2 2 . 5 0  2 . 5  • 0 
7 5 . 4  1 2 . 2 7 1 0 5 0 . 4 2 1 . 1 6 8  5 8 . 0 0 3 8 . 0 0 1 . 0  3 . 0 
2 1 4 . 1 10 . 2 6 1 0 5 0 . 4 2 4 . 0 2 7  8 2 . 5 0  1 4 . s o · 1 . 0  2 . 0 
8 8 . 6  9 . 0 7 1 0 3 3 . 6 1 2 . 1 4 8  7 4 . 0 0 2 2 . 0 0 3 . 0 1 . 0 













1 . 0  





· TABLE i· WEEK :6· 
Group Wei ght RB Ca WBCb Hbc P.CV% MCVd MC He MCHCf 
k9: 
Control 
1 5 3 . 1 8 7 . 4 8 1 . 1 5 1 2 . 0 7 3 8 . 2 5 5 1 . 1 4 1 "6 . 1 4 3 1 . 5 6 
2 4 3 . 1 8 7 . 3 6 1 . 0 6 1 2 . 4 3 4 0 . 5 0  5 5 . 0 3  1 6 . 8 9 3 0 . 6 9 
3 5 5 . 0 0 7 . 9 7 . 6 9 1 2 . 6 0 4 6 . 0 0 5 9 . 0 5 1 6 . 1 7 2 7 . 3 9  
4 5 7 . 2 7  7 . 8 1 1 . 1 2 1 2 . 2 8 3 5 . 0 0 4 4 . 8 1  1 5 . 7 2 3 5 . 0 9  
Treatment 
1 4 8 . 1 8 8 . 30 1 . 5 5 1 3 . 4 9  3 8 . 7 5 4 6 . 6 9 1 6 . 2 5 3 4  . . 8 1  
2 4 7 . 7 3 7 . 8 1 . 7 7 1 2 . 7 8 3 9 . 5 0 5 0 . 5 8 1 6 . 3 6  3 2 . 3 5  
3 5 2 . 7 3 9 . 2 3 1 . 1 7 1 1 . 8 2 3 7 . 0 0 4 0 . 0 9 1 2 . 8 1  3 1 . 9 5 
4 5 5 . 0 0 9 . 4 8 . 7 2 1 3 . 4 9  4 7 . 0 0 4 9 . 5 8 1 4 . 2 3 2 8 . 7 0  
5 4 1 . 8 2 8 . 4 8 1 . 8 0 1 3 . 3 5  3 7 . 5 0 4 4 . 2 2 1 5 . 7 4 3 5 . 6 0  
6 4 2 . 7 3 8 . 3 7 1 . 1 0 1 2 . 9 5 37 . 5 0 4 4 . 8 0 1 5 . 4 7 3 4 . 5 3 
7 5 1 . 8 2 7 . 8 1  1 . 0 6 11 . 4 7 3 3 . 5 0 4 2 . 8 9  1 4 . 6 9  3 4 . 2 4 
8 3 4 . 5 5  6 . 9 4  1 . 1 2 1 0 . 4 7 2 6 . 7 5 3 8 . 5 4  1 5 . 0 9  3 9 . 1 4 
aRBC x io 6;mm3 . 
bwBc x i o 4/mm3 . 
CHb g/1 0 0  ml . 
dMean Corpuscular Volume . 
eMean Corpuscular Hemoglobin . 
fMean Corpuscular Hemoglobin Concentration . -..J -..J 
Group Plasma 
Fe ug7dl Mn ug71 
Control 
1 8 2 . 7  2 . 0 0 
2 8 9 . 4  2 . 0 0 
3 1 0 2 . 0  2 . 0 0 
4 8 4 . 0 2 2 . 0 0 
. Treatment 
1 6 5 . 4  3 4 . 5 3 
2 1 1 2 . 8  2 1 . 5 0  
3 5 9 . 6  2 5 . 4 7  
4 1 4 2 . 9  1 4 . 6 0 
5 8 1 . 6  3 0 . 2 3 
6 1 6 8 . 7  11 . 3 2  
7 7 0 . 7  1 6 . 9 8 
8 6 2 . 2  3 .  4 0· 
RAW DATA 
TABLE 1 WEEK 6 CONT·INUED 













. .  
Red blood ce lls  .
.
. 
· Diffe�ehtial countsh 
· Fe ug/g Mn u·g/g ·1ym: · · ·n·eutro mo·n·o ·eosin 
1 1 9 6 . 5 8 3 . 0 6 3  8 2 . 0 0 1 5 . 5 0  1 . 0 1 . 5 
10 9 4 . 0 1 3 . 6 7 5  8 0 . 0 0 1 6 . 5 0  1 . 5 1 . 5 
1 1 1 9 . 6 6 2 . 7 6 3  8 4 . 5 0  1 0 . 0 0 3 . 0 2 . 0 
1 0 5 9 . 8 3 3 . 1 0 0  8 0 . 0 0 17 . 0 0 1 . 0  1 . 5 
I 
1 1 4 5 . 3 0 6 . 7 1 3  3 3 . 0 0  6 5 . 0 0 2 . 0  • 0 
9 5 7 . 2 6 6 . 2 5 0  6 2 . 5 0  3 1 . 0 0 6 . 0 • 5 
10 8 5 . 4 7 4 . 1 2 5  6 3 . 0 0  3 4 . 5 0 1 . 0  1 . 0 
9 4 8 . 7 2 5 . 5 0 5  5 9 . 0 0 3 8 . 5 0  2 . 5  . 0  
1 0 3 4 . 1 9 2 . 7 3 5  4 0 . 0 0 5 9 . 0 0  1 . 0 . o  
1 0 8 5 . 4 7 5 . 5 2 5  8 0 . 0 0  1 7 . 0 0 1 . 0 1 . 5 
10 8 5 . 4 7 2 . 7 5 7  6 8 . 0 0 . 2 8 . 0 0  2 . 5  1 . 5 
1 0 4 2 . 7 3 5· . -9 7 4  .7 4 . ·o o ·2 3 .  o o· · 3 . 0- · . . · .- o  
base 
. 0  
. 5  
• 5 





. o  
. 5  
. 0 
• 0 





TABLE 1 WEEK 7 
Group Weight RB Ca wscb Hbc PCV% Mcvd MC He MCHcf· 
kg 
. Control 
1 5 4 . 0 9  7 . 7 3 . 8 9 1 1 . 7 5 3 6 . 0 0 4 6 . 5 7  1 5 . 2 0 3 2 . 6 3 
2 4 3 . 1 8 7 . 6 3 . 8 9 1 2 . 1 8 4 0 . 0 0 5 2 . 4 2 1 5 . 9 6  3 0 . 4 5 
3 5 5 . 0 0  8 . 7 5 . 7 3 1 2 . 4 3 3 9 . 0 0 4 4 . 5 7 1 4 . 2 1  31 . 8 7 
4 5 8 . 6 4  8- . 1 2 1 . 2 2 1 1 . 7 3 3 6 . 0 0 4 4 . 3 3 1 4 . 4 5 3 2 . 5 8  
Treatment 
1 5 1 . 8 2 9 . 0 3 . 8 6 1 2 . 7 5 3 8 . 5 0 4 2 . 6 4 1 4 . 1 2  3 3 . 1 2  
2 4 7 . 2 7 9 . 2 9 . 8 5 12 . 9 2 4 0 . 5 0 4 3 . 6 0  1 3 . 9 1  3 1 . 9 0 
3 5 0 . 4 5 6 . 9 4 1 . 2 3 11 . 0 1 3 4 . 5 0 4 9 . 7 1 15 . 8 6 3 1 . 9 1 
4g 
5 4 4 . 5 5 8 . 1 9 1 . 0 2 1 2 . 4 3 4 0 . 0 0 4 8 . 8 4  1 5 . 1 8 3 1 . 0 8 
6 4 4 . 5 5 8 . 9 9 1 . 3 4 1 2 . 5 1  3 9 . 0 0 4 3 . 3 8  1 3 . 9 2 3 2 . 0 8 
7 5 4 . 4 5  9 . 1 5 1 . 12 11 . 0 6 4 0 . 0 0 ·4 3 .  7 2  1 2 . 0 9 2 7 . 6 5 
8 3 3 . 1 8 7 . 6 3 . 8 9 9 . 2 1 2 6 . 0 0 3 4 . 0 8 1 2 . 0 7 3 5 . 4 2 
aRBC x l o 6 ;mm3 . 
bwBc
.
x l0 4/mm3 . 
CHb g/1 0 0  ml . 
dMean Corpuscular Volume . 
eMean Corpuscular Hemoglobin . 
fMean Corpuscular Hemoglobin Concentration . 
gAnimal four of the treatment group died . ......J \0 
RAW DATA 
TABLE 1 WEEK 7: CONT-INUED 
Group Plasma Red blood ce lls  Di f ferential countsh 
Fe ug7dl Mn ug71 Fe ug7g Mn ug7g lym neutro mono eos in baso 
Contro l 
1 1 1 9 . 1 0 2 . 0 0 1 0 3 2 . 7 9 3 . 1 8 6  8 2 . 0 0 1 4 . 0 0  2 . 0 2 . 0 • 0 
2 1 0 0 . 9 0 2 . 0 0 1 0 5 7 . 3 8 5 . 6 5 2  8 1 . 5 0 1 3 . 5 0 ' 3 .  0 2 . 0 . 0 
3 9 7 . 5 4 2 . 0 0 1 0 4 9 . 1 8 2 . 6 6 0  8 1 . 0 0 1 4 . 5 0 3 . 5  1 . 0 . 0 
4 9 9 . 5 3  2 . 0 0 9 6 7 . 2 1 3 . 0 0 3  7 2 . 0 0  2 0 . 0 0 3 . 5  2 . 5  . 0 
Treatment 
1 9 4 . 5 4 7 . 9 0 1 1 1 4 . 7 5 1 0 . 3 2 2  4 3 . 0 0  4 8 . 0 0 7 . 5  1 . 5 . 0 
2 1 3 0 . 4 0 4 . 9 0 1 0 8 1 . 9 7 1 0 . 1 7 5  6 9 . 0 0 2 7 . 0 0 3 . 0 1 . 0 . 0 
3 8 8 . 6 4  1 3 . 5 0  1 0 8 1 . 9 7 6 . 8 6 6  7 1 . 5 0 2 4 . 0 0 4 . 0  . 5 . 0 
4g 
5 1 1 1 . 0 9 1 2 . 2 0 1 0 0 0 . 0 0 3 . 8 9 7  31 . 2 5 5 2 . 5 0  4 . 0  .. 0 . 0 
6 1 2 7 . 1 7 4 . 8 0 1 0 0 8 . 2 0 5 . 3 3 5  8 7 . 0 0 10 . 0 0 2 . 0  1 . 0  . 0 
7 1 0 1 . 9 0 8 . 3 3 1 0 2 4 . 5 9 3 . 4 7 9  8 0 . 0 0 1 6 . 0 0 3 . 5  . 5  . 0 
8 6 5 . 5 7  2 . 0 0 1 0 0 8 . 2 0 5 . 9 3 8  · 6 0 . s o· 3.6 . 0 O' . . 3 . - s  . 0 • 0 
hPercentage of 2 0 0  counts of lymphocytes , neutrophi ls , monocytes , eos inophils  and 




TABLE 1 WEEK 8 
Group Weight RB ca WBCb Hbc PCV% Mcvd MC He MCHCf 
kg 
Control 
1 5 4 . 0 9 . 7 . 7 3 . 8 9 11 . 7 5 3 6 . oo 4 6 . 5 7  1 5 . 2 0  3 2 . 6 3 
2 4 3 . 1 8 7 . 6 3 . 8 9 1 2 . 1 8 4 0 . oo 5 2 . 4 2 1 5 . 9 6 3 0 . 4 5  
3 5 5 . 0 0 8 . 7 5 . 7 3 12 . 4 3 3 9 . oo 4 4 . 5 7  1 4 . 2 1  3 1 . 8 7  
4 5 8 . 6 4 8 . 1 2 1 . 2 2 1 1 . 7 3 3 6 . oo 4 4 . 3 3  1 4 . 4 5 3 2 . 5 8 
Treatment 
1 5 1 . 8 2 9 . 0 3 . 8 6 1 2 . 7 5 3 8 . so 4 2 . 6 4  1 4 . 1 4  3 3 . 1 2 
2 4 7 . 2 7 9 . 2 9 . 8 5 1 2 . 9 2 · 4 0 . 50 4 3 . 6 0  1 3 . 9 1  3 1 . 9 0 
3 5 0 . 4 5 6 . 9 4 1 . 2 3 1 1 . 0 1 3 4 . 50 4 9 . 7 1  1 5 . 8 6  31 . 9 1 
4g 
5 4 4 . 5 5 8 . 1 9 1 . 0 2 1 2 . 4 3 4 0 . oo 4 8 . 8 4  1 5 . 1 8 3 1 . 0 8 
6 4 4 . 5 5 8 . 9 9 1 . 3 4 1 2 . 5 1 3 9 . oo 4 3 . 3 8  1 3 . 9 2 3 2 . 0 8 
7 5 4 . 4 5 9 . 1 5 1 . 1 2 11 . 0 6 4 0 . oo 4 3 . 7 2  12 . 0 9 2 7 . 6 5 
8 3 3 . 1 8 7 . 6 3 . 8 9 9 . 2 1 2 6 . oo 3 4 . 0 8 1 2 . 0 7 3 5 . 4 2 
aRBC x io 6;mm3 . 
bwBc x l o 4;mm3 . 
CHb g/1 0 0  ml . 
dMean Corpuscular Volume . 
eMean Corpuscular Hemoglobin . 
fMean Corpuscular Hemoglobin Concentration . 
gAnimal four of the treatment group died . °' ,_..., 
RAW DATA 
TABLE. '!: WEEK 8 CON.T.IN.UED. 
Group Plasma· Red blood cells · · Differential countsh 
Fe ug/dl Mn ug/l Fe ug/g Mn· ·ug/g lym · · ·n·eutro mono eos in baso 
Control 
1 9 1 . 7 0  2 . 0 0 1 0 2 5 . 6 4 8 . 7 6 0  7 9 . 5 0  1 7 . 0 0 2 . 0  1 . 0  . 5 
2 9 6 . 4 8 2 . 0 0 1 1 0 2 . 5 6 4 . 2 5 8  7 5 . 5 0 2 1 . 5 0  1 . 5 1 . 5 . 0  
3 9 2 . 3 1  2 . 0 0 1 0 4 2 . 7 3 2 . 6 5 0  3 1 . 8 7 6 8 . 0 0  2 . 0 i . O . 0  
4 8 4 . 2 6 2 . 0 0 1 0 0 0 . 0 0 2 . 6 5 0  8 9 . 0 0 8 . 0 0 1 . 5  1 . 0 . 5 
Treatment 
1 1 0 2 . 2 8 2 . 0 0 10 2 5 . 6 4 8 . 7 6 0  6 5 . 0 0  3 1 . 5 0 2 . 0 1 . 0  . 5  
2 8 7 . 8 7 2 . 0 0 1 0 7 6 . 9 2 1 1 . 1 7 6  7 8 . 0 0  1 5 . 0 0 3 . 0  4 . 0  . 0 
3 9 4 . 9 4 4 . 10 1 0 0 0 . 0 0 5 . 8 2 7  7 9 . 0 0 1 4 . 5 0 4 . 0  2 . 0  . 5 
4g 
5 1 3 1 . 9 1 4 . 3 0 9 9 1 . 4 5 4 . 1 1 3  8 3 . 0 0 1 2 . 5 0 . 3 . 0  1 . 5  . o  
6 1 2 1 . 2 4 2 . 0 0 1 0 2 5 . 6 4 5 . 3 7 5  8 2 . 5 0 1 2 � 0 0 5 . 0 . • 5 • 0 
7 1 2 7 . 4 9 7 . 4 9 1 0 1 7 . 0 9 . . . 5 . 5 0 0  8 7 . 5 0  1 5  •. o o  2 .  o . .  • 0 • 0 
8 7 2 . 8 7 3 . 7 8 1 0 2 5 . 6 4 · 6 .  O B3 7 5 . 0 0  2 1 . 0 0 'J .  0 1 . 0  • 0 





TABLE 1 WEEK 9 
Group Weight RBca wscb Hbc PCV% Mcvd . MC He MCHc f 
kg 
Control 
1 ' 5 4 . 5 5 . 6 . 5 7 1 . 1 8 11 . 3 6 3 8 . 0 0 5 7 . 8 4 1 7 . 2 9 2 9 . 8 9 
2 4 4 . 5 5 5 . 9 0 . 9 0 1 2 . 5 0 4 4 . 0 0 7 4 . 5 8  2 1 . 1 9  2 8 . 4 1 
3 5 3 . 1 8 8 . 7 0 1 . 0 4 1 3 . 0 6 4 2 . 50 4 8 . 8 5 1 5 . 0 1 3 0 . 7 3 
4 5 9 . 5 5 7 . 1 5 1 . 4 8 1 2 . 0 7 4 0 . 0 0 5 5 . 9 4 1 6 . 8 8 3 0 . 1 8 
Treatment 
1 5 2 . 7 3 8 . 2 3 1 . 11 1 2 . 9 6 4 3 . 0 0 1 5 2 .  2 5  1 5 . 7 � 3 0 . 1 4 
2 4 6 . 3 6  7 . 4 0 . 7 2 12 . 5 0 4 4 . 50 6 0 . 1 4  1 6 . 8 9 2 8 . 0 9  
3 5 0 . 4 5 6 . 2 1 . 9 6 1 0 . 9 0 3 5 . 50 5 7 . 17 1 7 . 5 5 3 0 . 7 0 
4g 
5 4 6 . 3 6  7 . 4 7 1 . 1 7 1 2· . 1 8 4 2 . 50 5 6 . 8 9 1 6 . 3 1 2 8 . 6 6  
6 4 5 . 0 0 7 . 6 0 1 . 2 4 1 1 . 9 6 4 0 . 50 5 3 . 2 9  1 5 . 7 4 2 9 . 5 3 
7 5 6 . 3 6  7 . 6 3 l_. 1 3  1 1 . 4 3 3 8 . 00 4 9 . 8 0 1 4 . 9 8 3 0 . 0 8 
8 3 2 . 2 7  7 . 1 5 1 . 4 8 1 2 . 0 7  3 0 . 00 5 4 . 3 5 1 7 . 0 5 3 1 . 3 7 
aRBC x 1 0 6/mm3 . 
bwBc x l o 4;mm3 . 
CHb g/1 0 0  ml . 
dMean Corpuscular Volume . 
eMean Corpuscular Hemoglobin . 
fMean Corpuscular Hemoglobin Concentration . 
gAnimal four of the treatment group died . 00 w 
RAW DATA 
TABLE. ·1 WEEK 9 CONT.INUED 
Group Plasma Red bTood ce·11s  
Fe ug/dl Mn ug71· Fe u9:7g · Mn ug7g lym · 
Control 
1 1 0 0 . 7 9 2 . 0 0 1 0 8 0 . 3 6 3 . 5 8 0  9 3 ·. 0 0  
2 1 0 2 . 6 0 2 . 0 0 1 0 0 0 . 0 0 4 . 0 0 5  8 8 . 5 0  
3 1 1 8 . 4 6 2 . 0 0 10 5 3 . 5 7 2 . 7 1 8  9 2 . 5 0  
4 1 2 5 . 4 8 2 . 0 0 10 0 0 . 0 0 2 . 4 2 7  7 5 . 3 0  
Treatment 
1 1 3 5 . 0 0 2 . 0 0 10 4 4 . 6 4 11 . 2 2 6  7 9 . 5 0 
2 10 5 . 9 4 2 . 0 0 10 80 . 3 6 11 . 9 1 7  8 6 . 0 0  
3 1 2 6 . 8 5 2 . 0 0 1 1 4 2 . 8 5 8 . 3 1 3  8 5 . 0 0 
4g 
5 14 1 . 2 4 2 . 0 0 1 0 4 4 . 6 4 5 . 8 5 0  8 5 . 0 0 
6 1 6 6 . 0 3 3 . 2 3 9 8 2 . 1 4  6 . 2 6 2  9 1 . 0 0  
7 1 3 8 . 1 3 3 . 2 3 10 1 7 . 8 5 6 . 4 9 3  7 8 . 0 0  
8 9 8 . 4 4 3 . 3 9 1·0 0 8 .  9 2  5 . · 9 7 4 · · s 3 . o o 
. . . . . . . . .  
Diff·ere·ntia'l co·untsh 
n·eutr·o mono eos in 
5 . 0 0 . 5 1 . 5 
1 0 . 5 0 . 0 1 . 0 
5 . 0 0 2 . 0 . 5 
2 2 . 0 0 1 . 0  1 . 0 
1 7 . 5 0  2 . 0 1 . 0 
1 1 . 0 0 1 . 0  2 . 0 
10 . 5 0 2 . 5  2 . 0 
1 0 . 5 0 1 . 0 3 . 5 
6 . 0 0 2 . 0  1 . 0  
. .  2 0 . 0 0  . . 1 .  0 . . . 1 -. 0 
4 2 . 0 0 3 . 0  2 . 0  
baso 
. 0 






. o  
• 0 
• 0 
. •  0 




TABLE 2 . . LEAST- SQUARES MEANS AND STANDARD ERROR FOR 
CONTROL AND TREATMENT GROUPS (WEEKS ONE THROUGH NINE ) . 
8 5  
Bas i s  Group Means Standard error 
We�ght (kg )  Control 
Treatment 
Red Blood Cel ls  Control 
Treatment 
Wh ite Blood Ce l l s  Control 
Treatment 
Hemoglob in Control 
Concentration Treatment 









Red Blood Cel l  
Iron 
Plasma I ron 






















5 1 . 6 2 0  
4 8 . 9 1 0  
7 . 9 8 8  
7 . 9 3 5 
1 . 0 7 9  
1 . 1 6 2  
1 2 . 5 0 0  
1 2 . 7 0 3  
4 2 . 2 2 7  
4 1  .. 9 2 1  
5 3 . 8 5 7  
5 4 . 0 5 3  
1 5 . 8 7 1  
1 6 . 2 9 3  
2 9· . 8 6 4  
3 0 . 8 2 5  
1 0 3 9 . 8 7 4  
1 0 3 5 . 8 1 0  
1 2 7 . 4 7 6  
1 3 4 . 5 0 5  
2 . 1 8 8  
5 . 8 5 2 
3 . 4 5 9  
4 . 2 0 0  
7 9 . 5 3 0  
7 5 . 2 8 3  
+ 1 . 0 2 0  
+ • 7 3 0 
+ . 1 5 0  
+ . 10 9  
+ . 3 8 7  
+ • 2 8 0  
+ . 1 3 8  
+ . 1 0 0  
+ . 7 3 8  
+ • 5 3 4 
+ 1 . 3 2 4  
+ • 9 5 8  
+ . 31 5  
+ • 2 2 8  
+ • 4 5 6 
+ • 3 3 0 
+ 9 . 2 6 8  
+ 6 . 7 0 8  
+ 4 . 7 3 9  
+ 3 . 3 9 3  
+ • 5 5 0  
+ • 4 0 1  
+ • 2 3 9  
+ . 1 7 3  
+ 1 . 7 3 2 
+ 1 . 2 5 3  
TABLE 2 .  CONTINUED . 
Bas i s  Group 
Monocyte Control 
Count Treatment 
Neutrophi l  Control 
Count Treatment 
Eos inoph i l  Control 
Count Treatment 
Basophil  Control 
Count Treatment 
8 6  
Means S tandard error 
1 . 8 4 7  + . 1 8 8  
2 . 3 2 7  + . 1 3 6  
1 5 . 9 9 7  + 1 . 6 5 3  
2 1 . 1 1 3  + 1 . 1 9 6  
1 . 9 0 2  + . 1 8 6  
1 . 2 8 1  + . 1 3 4  
• 2 6 3  . + . 0 4 8  
. 1 1 3 + . 0 3 5  
TABLE 3 .  LEAST-SQUARES MEANS AND STANDARD ERROR FOR 
CONTROL AND TREATMENT GROUPS (WEEKS FIVE THROUGH NINE ) . 
8 7  
Bas i s  Group Means Standard error 
Weight (kg ) 










Packed Cel l  Control 
Volume Treatment 
Mean Corpus- Control 
cular Vo lume Treatment 
Mean Corpuscu- Control 
lar Hemoglobin Treatment 
Mean Corpuscular Control 
Hemoglobin Treatment 
Concentration 




Plasma I ron Contro l 
Treatment 
Red B lood Ce l l  Contro l 
Manganese Treatment 




5 2 . 4 3 2 
4 6 . 9 9 2  
7 . 9 2 3  
8 . 0 9 3  
1 . 0 5 9  
1 . 1 5 0  
1 2 . 4 1 1  
1 2 . 2 1 0  
3 9 . 9 1 0  
3 7 . 7 7 0  
5 1 . 0 4 7  
4 7 . 0 7 1  
1 5 . 8 3 8  
15 . 2 4 2  
31 . 2 1 9 
3 2 . 6 4 2  
1 0 5 7 . 9 6 2  
1 0 4 4 . 7 5 6  
1 0 1 . 0 2 1  
1 1 2 . 3 5 2  
3 . 3 5 6  
5 . 8 1 3  
1 . 9 1 0  
8 . 7 1 0  
8 0 . 2 6 5  
7 1 . 5 8 5 
+ 1 . 4 8 7 
+ 1 . 0 9 5  
+ • 2 0 2  
+ . 1 4 8  
+ 
+ 
. 0 5 7  
. 0 4 2  
+ • 2 0 7  
+ . 15 2  
+ . 9 9 2  
+ . 7 3 1  
+ 1 . 2 1 8  
+ • 8 9 8  
+ • 3 4 6  
+ • 2 5 5  
+ • 6 7 2  
+ . 4 9 5  
+ 1 0 . 5 5 1  
+ 7 . 7 7 4  
+ 6 . 5 7 5  
+ 4 . 8 4 5  
+ • 4 0 7  
+ • 3 0 0  
+ • 9 9 2  
+ · • 7 31 
+ 2 . 5 1 2  
+ 1 . 8 5 1  
TABLE 3 .  CONTINUED . 
Bas i s  Group 
Monocyte Control 
Count Treatment 




Basophi l Control 
Count Treatment 
8 8  
Means Standard error 
1 5 . 4 0 0  + 2 . 4 0 2  
2 4 . 6 3 2 + 1 . 7 6 9  
2 . 2 5 0  + . 2 6 2  
2 . 6 7 1  + . 19 3  
1 . 8 0 0  + . 2 5 1  
1 . 1 4 6  + . 1 8 5  
. 1 7 5  + . 0 5 0  
. 0 7 8  + . 0 3 7  
